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3Abstract
The human microbiota refers to the ecosystem of microorganisms living on or within the
human body, and is increasingly being implicated as a regulator of health and disease.
Abnormal alterations in the development or composition of the intestinal microbiota
are referred to as dysbiosis. However, the reciprocal interactions between the microbi-
ota and the host’s diet, immunology and genetics can in turn make it extremely difficult
to distinguish the cause and effect of dysbiosis in pathologies. Synthetic biology has
facilitated the design and creation of more complex and clinically relevant genetic cir-
cuits. The commensal nature of the intestinal microbiota and its constituents provide a
number of well tolerated microorganisms such as Escherichia coli NISSLE 1917 (EcN)
that could be used as powerful investigative tools.
The use of antibiotic selection within synthetic circuits would eventually hinder their
investigative power during microbiota experiments. Toxin-Antitoxin (TA) post segreg-
ational killing systems are a naturally occurring bacterial mechanism to maintain plas-
mid stability. Here we show that the Axe/Txe TA system from Enterococcus faecium
was able to significantly outperform the more widely used Hok/Sok system to maintain
the stability of fluorescent and luminescent reporter plasmids in EcN without antibiotic
selection during both liquid culture and in vivo animal experiments.
In addition, we created a sensor circuit that in EcN could detect both exogenous and
bacterial-derived reactive nitrogen species, which are thought to play a crucial role in
the human host inflammatory response. We also developed biosensors for pH and the
short-chain fatty acid propionate. Finally, we demonstrated that an EcN sensor could
detect and report on environmental signals in vivo from the intestines of the Caenorhab-
ditis elegans worm. Synthetic biological tools such as these could help further elucidate
the underlying role of the microbiota in conditions such as inflammatory bowel disease
and cancers of the gasterointestinal tract.
4UCL Impact Statement
The research presented here has the potential to have a wide impact inside and out-
side academia. We have shown that we can apply synthetic biology principles and
methodologies to engineer a commonly used probiotic strain of Escherichia coli called
Escherichia coli Nissle 1917. We initially demonstrated that a less well characterised
plasmid stability mechanism functions better in this strain than the current standard
mechanism. After publication of these findings, this will enable researchers to create
more robust experiments and gain deeper insights into the intestinal microbiome.
Next, we created and characterised a variety of bacterial biosensors with this strain.
This will have an initial academic impact on the research carried out within intestinal
microbiome engineering. Furthermore, this academic research could help eventually
create clinically relevant treatments that can help understand and combat pathologies
such as inflammatory bowel disease and cancers of the gasterointestinal tract.
Lastly, we demonstrated that the Caenorhabditis elegans worm can be used as a simple,
powerful and economical animal model for live intestinal experiments. Once published,
these findings will encourage researchers to use this model as a useful biological tool for
intestinal microbiome investigations. In line with the principles of 3Rs (replacement,
reduction and refinement) within animal research, this can help significantly reduce the
use of regulated vertebrate animals such as mice, and subsequently, it will also help
reduce the amount of money and time needed to carry out these type of experiments.
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1. Background
1.1 Introduction to the Human Microbiome
As a result of co-evolution over millions of years, the skin, respiratory and intestinal
tracts of humans are colonised by over a 1000 species of microbes soon after birth.
The terms ‘microbiota’ and ‘microbiome’ are used to describe the collective microbial
community which inhabit a certain environment and the collective genomic contents of
this community, respectively. It is now known that these microbes have essential roles
in maintaining normal physiology [1]. Ongoing consortium studies like the Human
Microbiome Project and MetaHIT (Metagenomics of the Human Intestinal Tract) have
established that the human microbiome contributes 360 times more unique protein-
coding genes than human cells (8 million in comparison to 22,000) [2, 3]. Having
identified this vast and unexplored genomic ‘dark-matter’, a significant emphasis has
been placed on slowly unraveling the physiological importance of the microbiota in
relation to human health and disease. For the purpose of clarity, this piece of work will
only focus on the gut microbiota which encompasses the entire gastrointestinal tract
(Figure 1.1).
Instead of several segregated components, the human gut microbiome can be con-
sidered a complex and multifaceted ecosystem that exhibits spatiotemporal synergy
[5], metabolic competition and cooperation [6, 7] and intercellular interactions such as
quorum sensing [8]. Quorum sensing is one of the most widely characterised micro-
bial communication systems. Using a diffusible molecule (AHL), the system creates
a signalling interaction which results in the correlation of gene expression in response
to fluctuations in the population density of a community [9]. In a densely populated
environment such as the intestines, multi-species communities also use mobile genetic
15
Stomach 
Large 
Intestine: 
Caecum, 
colon 
Rectum 
Small Intestine: 
Duodenum, jejunum 
Small Intestine: 
 ileum 
Esophagus 
Figure 1.1: Drawing of the human gastrointestinal tract indicating the esophagus,
stomach, small intestines, large intestines and rectum. Image adapted from [4].
elements such as plasmids and bacteriophages for horizontal gene transfers (HGT) to
share beneficial genes with neighbours and preserve the stability of the niche [10, 11, 12].
1.1.1 The Gut Microbiome in Human Health
The host immune system has evolved to simultaneously allow colonisation by symbi-
otic microbiota whilst also containing the capacity to fight against pathogens. It is
hypothesised that individual members of the microbiota maintain this gut homeostasis
by balancing pro-inflammatory and regulatory host responses throughout the develop-
ment of the immune system [13]. It is now known that the host age [14], diet [15] and
immunological state [16] can significantly affect the gut microbiota (Figure 1.2). This
coevolution is known to be beneficial to the host as the microbiota aids in the devel-
opment of the infant immune system [17] and provides protection against pathogenic
colonisation [18]. Recently, the discovery that the gut microbiota can also communicate
with the central nervous system through neural and endocrine pathways led to the real-
isation of a microbiota-gut-brain axis that is linked to the host’s brain and behaviour
[19]. Another vital role for the microbiota is that additional genes provided by the
microbiome facilitate the extraction of a wide range of otherwise inaccessible nutrients
from the diet. A major example of this is microbial fermentation of ingested carbo-
hydrates into short-chain fatty acids (SCFAs) such as butyrate, acetate and propionate
[20, 21].
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Figure 1.2: Human gut microbiome composition across the life cycle [22, 23]. The
graphic shows that from a young age, the diversity and stability of the gut microbiome
increases. However, this stability and diversity is reduced during old age.
1.1.2 Dysbiosis
Due to the integrated relationship with the host, both the microbiota and the micro-
biome can be significantly altered during human disease. This abnormal alteration is
referred to as dysbiosis [24]. The reciprocal interactions between the microbiota and
the host’s diet, immunology and genetics can in turn make it extremely difficult to
distinguish the cause and effect of dysbiosis in pathologies. It is also known that a
diseased state can lead to changes in the microbiota through various mechanisms such
as changes in bowel functions, eating habits and the use of antibiotics [25]. However,
recent findings are indicating that certain host genetic variants predispose individuals
towards dysbiotic states and these alterations in turn are a key feature in disorders of
metabolism [26] and immunity [27].
1.1.3 Disease
As the epithelial cells of the gut lumen are constantly exposed to the microbiota and
its metabolites, the host immune response can be a source of a number of maladies.
17
Inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn’s disease are
thought to be caused by a dysfunctional immune response that leads to dysbiosis and
in turn chronic low levels of inflammation [13]. It is hypothesised that this erroneous
immune response is due to a combination of environmental and genetic factors [28]. The
gut microbiota has also subsequently been implicated in allergies [29] and autoimmune
conditions such as rheumatoid arthritis [30], lupus [31] and type 1 diabetes [32].
1.1.4 Diet
The host diet has a vital role in shaping the microbiota composition and in turn the
downstream secondary metabolites that are produced directly in the gut lumen. In
fact, it is now known that up to 10% of the metabolites found in mammalian blood
are of bacterial origin [33]. The role of diet-induced obesity on the gut microbiota was
first established over a decade ago when it was shown to decrease the abundance of
Bacteroidetes phyla whilst increasing the proportion of Firmicutes phyla [34]. It was
then subsequently shown that this altered obese microbiota composition was enough
to cause an increase in total body fat in germ-free mice by increasing the capacity to
harvest energy from their diet [35]. Further research also demonstrated that the gut
microbiota is implicated in other metabolic disorders such as cardiovascular disease
[36] and type 2 diabetes [37]. One of the most widely investigated interactions of
microbial metabolites is with colorectal cancer, the third most common cause of cancer
mortality in the world [38]. Certain fermentation products such as SCFAs have been
shown to prevent colorectal carcinogenesis by having anti-inflammatory [39] and anti-
apoptotic [40] effects on the cells of the gut lumen. Conversely, other pro-inflammatory
bacterial metabolites such as secondary bile acids and hydrogen sulphide are thought
to contribute to colorectal carcinogenesis through reactive oxygen species (ROS) and
reactive nitrogen species (RNS) [41, 42, 43]. Secondary bile acids are formed from
colonic bacteria metabolising the primary bile acids that are synthesised by the liver.
Alongside their pro-inflammatory effects, these compounds have also recently been
associated with providing resistance to pathogenic Clostridium difficile infection [44].
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1.2 Introduction to Synthetic Biology
Over the last 15 years, synthetic biology has emerged as an interdisciplinary field
that integrates many facets of biology and engineering. Since the characterisation
of deoxyribonucleic acid (DNA), the steady unravelling of this fundamental code of
life has revealed the complexity of the genetic framework and the biological systems
that it so delicately regulates. The genetic networks found in cells utilise a network
of interacting genes and proteins for signalling, growth, division, and differentiation.
Through the assimilation of techniques from disciplines such as chemical engineering,
computer science, and electrical engineering, synthetic biology is concerned with fur-
ther elucidating these complex biological systems and in turn manipulating them for
a novel or alternative purpose. These purposes span several fields within themselves
and includes the synthesis of valued chemicals, environmental remediation and disease
therapy [45, 46].
1.2.1 Engineering Approaches in Synthetic Biology
Since the early emergence of the field, engineering concepts such as abstraction, de-
coupling, and standardisation were proposed to enable the efficient scaling up of the
biological design process [47]. In order to be able to handle the complex genetic pro-
cess, the concept of abstraction encourages a hierarchal dissection into different design
levels such as DNA, parts, devices and whole systems. Together with decoupling, a
strategy used to reduce a complicated problem into several simpler tasks that can be
reassembled, the design of a specific part, device, or system can be compartmentalised
and simplified. The standardisation of both the design process and the physical as-
sembly was encouraged to enable a platform on which data, parts, and devices could
be shared. Due to the complexity of engineering biological systems, these approaches
still lead to a relatively slow and laborious ‘design, test and build’ cycle. While proof-
of-concept circuits with a small number of standardised parts are achievable, the move
towards large-scale systems with numerous circuits require a more complex design cycle
(Figure 1.3). This modelling, redesign and verification of parts and systems in silico,
rapidly reduce the cost and length of time needed.
An efficient and productive design cycle becomes a necessity when using complex
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Figure 1.3: Design cycle for engineering genetic circuits. Diagram demonstrating the
multiloop process in the design cycle of genetic circuits.
Promoter Ribosome Binding Site Protein Coding Sequence 
Terminator 
Figure 1.4: Biological parts in a synthetic protein coding device. A protein coding
sequence could be for Green Fluorescent Protein (GFP).
parts and devices to enable programmable functionality from engineered genetic circuits
[46]. Borrowing from fields such as electric engineering, synthetic biology has formed
biological parts that act as a building block in a genetic circuit and perform a spe-
cific function such as regulating transcription, regulating translation or binding protein
domains. The combination of a promoter, a ribosome binding site, a protein coding
sequence, and a terminator is all that is needed for the expression of a single protein
and to kickstart the circuit design process (Figure 1.4). With an ever increasing cata-
logue of different parts, several independent libraries have now been publicly released
with the relevant information about their compatibility and function [48]. Building on
this growing catalogue of parts, synthetic biologists have been able to construct several
types of higher-order circuits. These components include switches [49], time delayed
circuits [50], memory elements [51], logic gates [52] and genetic oscillators [53].
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1.2.2 Therapeutic Applications of Synthetic Biology
Through the use of DNA as building blocks, this interdisciplinary field has gone on
to vastly expand our knowledge base and push the boundaries of both prokaryote and
eukaryote biology. These span from fundamental advancements such as the creation of
non-natural xeno-nucleic acids (XNA) and polymerases [54] to the redesign and pro-
duction of numerous fully functioning chromosomes from the eukaryote Saccharomyces
cerevisiae yeast [55]. The ever expanding toolbox of synthetic biology has resulted in
numerous therapeutic applications that not only rely on genome engineering but also
on the design and integration of synthetic genetic circuits.
Using yeast, metabolic engineers were able to vastly reduce the cost of produ-
cing artemisinic acid, the precursor to the life-saving and expensive antimalaria drug
artemisin [56]. More recently, the same concepts were applied to demonstrate that
yeast could be engineered to biosynthesise opioids [57]. In order to tackle the increas-
ing burden of antibacterial resistant microbes, it was shown that the effectiveness of
three major classes of antibacterial drugs can be improved 5000-fold by using engin-
eered bacteriophages to disrupt the microbial defence response to the drugs [58]. Other
strategies include the design of genetics circuits that enabled laboratory E. coli to spe-
cifically recognise, migrate towards and kill pathogenic Pseudomonas aeruginosa [59].
Due to the fact that several genera of bacteria are known to naturally accumulate in the
hypoxic environment of tumours, synthetic biology techniques have also been used in
the field of cancer therapeutics [60]. It was shown that through a synthetic circuit, the
activity of HIF-1α, a hypoxia-inducible factor, could be coupled to the production of
cytosine deaminase, an enzyme that converts the 5-fluorocytosine prodrug to the much
more toxic and chemotherapeutic 5-fluorouracil [61]. When E. coli was engineered to
incorporate this circuit, it would localise at tumours and increase the prodrug sensitiv-
ity to human cancer cells expressing HIF-1α. The recent development of DNA-editing
tools such as CRISPR/Cas9 has paved the way for precise and rapid genome engineer-
ing experiments across many species, including bacteria [62]. A recent example in the
field of regenerative medicine showed that CRISPR/Cas9 could be used to inactivate
62 copies of the porcine endogenous retrovirus (PERV) in a pig cell line in hope of
eventually improving the safety of porcine-to-human xenotransplantation [63].
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1.3 Approaches to Investigating and Engineering the Mi-
crobiota
1.3.1 Introduction
The use of synthetic biology to engineer the intestinal microbiota has the potential
to provide a wide variety of therapeutic applications. This community consists of a
wide variety of well-tolerated microorganisms that occupy a very large and interactive
buffer zone between the host and the external environment. With a broadening set of
experimental tools and approaches being developed, these microogranisms are becom-
ing increasingly engineerable. Researchers have tried to harness this commensal ability
to deliver synthetic genetic circuits and novel therapeutics to the host via the intest-
ines. These approaches have used a number of different bacterial species and looked at
tackling a range of conditions such as pathogenic infection [64], metabolic disease [65]
and cancer [66]. Recent work has even demonstrated that probiotics engineered with
multifaceted genetic circuits could be used to monitor environmental signals within the
mammalian gut [67, 68].
It can be argued that the incorporation of even more advanced components and
techniques from synthetic biology is vital for the realisation of the full therapeutic and
diagnostic potential of engineering the microbiota. Even with the use of chassis that
are generally recognised as safe (GRAS) organisms, there now must also be serious
considerations for the regulation, safety and biocontainent of such approaches. One
particular safety concern is the spread of recombinant DNA from engineered strains
to native strains as natural horizontal gene transfer is known to be prevalent in the
intestines [69]. Another major concern is the escape of the engineered organism into
the environment or another human being. Incorporating conditional kill-switches into
circuits [70], or developing auxotrophic strains that cannot replicate outside of the
gut [71] are methods that have successfully been used for biocontainment. Indeed,
auxotrophy was the sole biocontainment strategy used during early clinical trials with
engineered probiotic Lactobacilli strains [72].
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1.3.2 Bacterial Vectors for Intestinal Microbiota Engineering
With the human microbiome consisting of over 1500 species, there is a great deal of
variety in the vectors chosen by researchers. This decision is primarily based on two
factors; the ease with which the strain can be manipulated in a laboratory setting and
its suitability to the destined niche (Figure 1.5). A balance must be struck between
convenience in the laboratory and the eventual relevancy to the target.
The intestines are found to be mostly anaerobic with some variation in oxygen con-
centration throughout. In line with this, microbes found in the intestines are either
obligate anaerobes (that are harmed by the presence of oxygen), aerotolerant anaer-
obes (which can tolerate the presence of oxygen) or facultative anaerobes (which can
grow with or without the presence of oxygen) [73]. With advancements in molecular
biology methods and an expansion in the repertoire of genetic parts and methods, an
ever increasing selection of bacteria have been used in the laboratory to augment our
understanding of the gut microbiome (Figure 1.6). Recent innovations in our ability
to culture new strains from the human gut will undoubtedly expand this toolbox [74].
In addition to some Lactobacilli strains, E. coli NISSLE 1917 (EcN) is one of the
most widely studied clinical probiotic strains to date. This particular strain was isolated
by Alfred Nissle in 1917 from the faeces of a soldier who did not fall ill with infectious
diarrhea like his companions [75]. Since then, it has been classed as a non-pathogenic
and non-invasive member of the E. coli family and does not produce any enterotox-
ins or cytotoxins. In addition to this, it has also been demonstrated that the strain
possesses immunomodulating properties, reinforces the intestinal-epithelial barrier and
acts antagonistically against other pathogenic entero-bacteria [76]. Due to these char-
acteristics, several clinical studies have shown that EcN can be therapeutically effective	
Laboratory Suitability Destined Niche Suitability 
- How convenient it is to culture (time, money, equipment) - Prevalence in the destined niche 
- How easy it is to perform DNA manipulation - Stability in the destined niche 
- Genome information - Virulence in the destined niche 
- Repertoire of available genetic parts - Clinical data 
- Safety and virulence   
- Published methods and tools  
Figure 1.5: Considerations behind choosing a chassis for microbiota investigations.
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Figure 1.6: Examples of engineered commensal microbes [64, 80, 81, 82, 83, 84, 85].
in the treatment of ulcerative colitis, Crohn’s disease and acute diarrhea [77, 78, 79].
After oral administration, the strain is capable of rapidly colonising the large in-
testine and cecum for up to several months in a stable manner [76, 86]. As a result
of the clinical investigations of EcN, an effort was also recently made to sequence and
publish the entire genome of the strain [87]. Due to these characteristics and the fact
that EcN is a member of the E. coli family, a number of researchers have used the strain
to investigate the potential of synthetic biology to engineer and monitor the intestinal
microbiome. It can be argued that as a plethora of suitable genetic parts, culturing
methods and other microbiology tools already exist for E. coli, EcN is therefore an
ideal commensal vector for microbiota engineering.
1.3.3 Current Approaches
To date, there have been multiple approaches with different bacterial chassis in an
attempt to use synthetic biology to design therapeutic tools to monitor and fight dis-
eases. The most basic of these approaches include the engineering of a chassis to
produce a beneficial compound directly in the gut. One of the first examples was the
engineering of Lactococcus lactis to secrete recombinant human anti-inflammatory cy-
tokine IL-10 directly in the intestines to reduce colitis as a form of treatment for IBD
[88]. A more recent example is the transformation of EcN with a plasmid producing
N-acylphosphatidylethanolamines (NAPEs), the precursors to a family of lipids which
are synthesised in the intestines in response to feeding and known to reduce food in-
take [65]. Mice that received this modified EcN strain showed significantly lower food
intake, adiposity and insulin resistance in comparison to control bacteria. In a similar
approach, EcN was also successfully engineered with a plasmid to produce β-carotene
in hope of eventually preventing vitamin A deficiency in the developing world [89].
Another example of this approach involved the use of engineered EcN to disrupt
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the quorum sensing pathways of V. cholerae. This pathogen is known to control its
population density and the amount of cholera toxin being produced via quorum sensing
molecules cholera autoinducer 1 (CAI-1) and autoinducer 2 (AI-2). When both of these
molecules are high, virulence factors such as cholera toxin are no longer expressed.
In order to disrupt this pathway and reduce virulence, EcN was transformed with a
plasmid which constitutively expresses CqsA, the gene for CAI-1. In a mouse model, the
ingestion of this engineered strain of EcN before V. cholerae administration significantly
reduced cholera toxin production and mortality [64].
In order to demonstrate the versatility of commensal strains like EcN as carrier
systems, efforts were made to create circuits that can be controlled in a temporal and
quantitative manner. In line with this, it was shown that EcN can be engineered with
synthetic circuits with promoters ParaBAD, PrhaBAD and Ptet which can be induced with
L-arabinose, L-rhamnose or anhydrotetracycline, respectively [86]. These promoters
were placed upstream of the luxCDABE operon to create an inducible luminescent
reporter. When these strains were administered orally and colonised the intestines,
each synthetic circuit was shown to have a specific in vivo induction profile once the
respective inducer substances were administered either orally or intravenously. Tools
like this demonstrate the feasibility of precisely controlling gene expression when a
chosen vector reaches and colonises a specific niche in the host.
As well as precise control, synthetic biology has also been used to incorporate more
complex genetic parts into these synthetic circuits (Figure 1.7). A circuit harbouring
both a switch element and memory element could be used in a non-pathogenic labor-
atory strain of E. coli to sense and report on stimuli directly from the gut of a mouse
model [67]. Once the stimuli was sensed in the gut, in this case the inducer tetracycline
(ATC), the chassis uses a stable memory element to hold the state over a number of
passages and days. More recently, another stimuli sensing memory switch was used in
Bacteroides thetaiotaomicron but with CRISPR-interference technology instead [81].
The incorporation of an integrase element into a sensor circuit also enabled researchers
to amplify the detection limits of a bacterial biosensor that could detect pathological
biomarkers in human clinical samples [90]. Other examples include the use of toxin-
antitoxin (TA) systems (Chapter 2) to stabilise genetics circuits in EcN so that it can
non-invasively detect and signal liver metastasis after oral administration [91]. Meth-
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Figure 1.7: Examples of the repertoire of synthetic circuit functions that can be incor-
porated into engineered strains for intestinal microbiome investigations.
ods like this indicate that it is possible to monitor the complex environment of the gut
and in turn elucidate mechanisms behind perturbations and pathologies.
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1.4 Thesis Aims
This body of work set out to investigate the use of synthetic biology tools for unraveling
the underlying mechanisms of the complex and multifaceted intestinal microbiota. In
addition to building on the latest research in these dynamic fields, attempts were made
to broaden the established methodologies and approaches currently in use.
Chapter 2: This piece of work aimed to design, test and evaluate the functional-
ity of a number of different PSK systems in stabilising fluorescent and bioluminescent
reporter circuits in the probiotic EcN strain in vitro and in vivo. This included:
1. The TA Hok/sok (HS) system derived from the parB locus of E. coli.
2. The TA Axe/Txe (AT) system derived from the pRUM plasmid of E. faecium.
3. The microcin V (MCC) bacteriocin system derived from E. coli.
Chapter 3: This piece of work aimed to design, test and evaluate a range of thera-
peutically relevant sensors in the probiotic EcN strain. This included:
1. A sensor based on the yeaR-yoaG operon that can detect a range of RNS such
as nitric oxide, nitrate and nitrite.
2. A sensor based on the prpBCDE operon that can detect the SCFA propionate.
3. A sensor based on the cadBA operon that can detect changes in external pH.
4. A sensor based on the putative promoter region of the BBr_0838 gene that can
detect bile acids.
Chapter 4: This piece of work aimed to investigate the use of C. elegans as a live
model for characterising an inducible EcN bacterial biosensor in vivo. This included:
1. Developing an inducible reporter system that can be detected quantitatively in
vivo.
2. To establish whether C. elegans can develop and grow solely on EcN.
3. The development of an induction assay whereby the signal of an EcN biosensor
can be detected and quantified from the C. elegans intestines in vivo.
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1.5 Thesis Organisation
This thesis is organised in the following manner:
• Chapter 1: Background.
• Chapter 2: Stabilising Plasmids in E. coli Nissle 1917 Through Post-segregational
Killing Mechanisms.
• Chapter 3: Design and Construction of Therapeutically Relevant Bacterial Sensors.
• Chapter 4: Caenorhabditis elegans: An Emerging Model for Studying the Intest-
inal Microbiota.
• Chapter 5: Conclusions.
• References.
• Appendix.
Experimental Chapters 2, 3 and 4 include their own introductory Background sec-
tion and a stand-alone Materials and Method section.
1.6 Work Carried Out by Other Individuals
Chapter 2: Alex Fedorec (Barnes Lab, UCL) was responsible for cloning the MCC
constructs and we jointly ran the plasmid loss experiments throughout. Alex also
plotted all the plasmid loss curves for the experiments. Anjali Doshi (Danino Lab,
Columbia University, USA) was responsible for cloning the pHelp promoter into all
the p26_Lux constructs. Anjali also performed all animal model experiments with the
luminescent constructs and kindly shared the experimental results.
Chapter 4: The IPTG inducible pLac_GFP plasmid was cloned from the OG241
plasmid by David Gonzales (MRes student in Barnes Lab).
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2. Stabilising Plasmids in E. coli Nissle
1917 Through Post-segregational Killing
Mechanisms
2.1 Introduction
The rapid advancement of microbiology techniques and DNA manipulation methods
has facilitated an increasing level of complexity in genetic engineering. These DNA
manipulation methods have evolved from standard restriction enzyme and PCR cloning
to more recent methods such as Golden Gate cloning [92] and Gibson assembly [93]. It is
fundamental that with this engineering, the desired outcome is stable and reproducible.
To date, genetic engineering of prokaryotes has either been carried out directly on the
host chromosome or on plasmids; small circular DNA molecules that can replicate
independently of the chromosome [94]. These plasmids are naturally found in most
bacteria and often carry beneficial genes such as antibiotic resistance [95]. Due to their
easy manipulation with DNA polymerases and molecular restriction enzymes, artificial
plasmids are a fundamental biological tool and have been widely used as vectors in
molecular cloning.
In the case of engineering a chosen host to contain a length of foreign DNA such
as a reporter circuit, it would be ideal to integrate the DNA sequence directly into the
genome to achieve a stable transformation. However, integration of a large number of
genes such as those found on a synthetic gene circuit can be technically challenging
and time consuming [96]. Whereas next generation tools such as lambda Red [97]
and CRISPR-Cas9 [98] are rapidly changing this landscape, there is still much debate
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on the unintended consequences of inserting large amounts of foreign DNA into the
genome of bacterial hosts. In light of these factors, non-integrating plasmids are still
widely used as DNA cloning vectors. However, these plasmids are not inherently stable
in the transformed host after division. If a gene on a plasmid confers a metabolic
burden on the host, plasmid-free progeny can rapidly outgrow plasmid containing cells
due to the negative selective pressure [99]. This would result in the complete loss of
the desired synthetic construct and therefore antibiotic resistance markers are widely
used in a research environment to impose a selective pressure and maintain plasmid
stability. However, the likelihood of horizontal gene transfer makes the use of antibiotics
unsuitable in many clinical [100] and industrial [101] applications of synthetic biology.
In the case of the intestinal microbiota, the use of antibiotics would also immensely
alter the native environment and significantly impact investigations [102].
Some plasmids have naturally evolved a number of mechanisms to prevent them-
selves from being dropped from the constantly dividing host. All plasmids studied to
date have been shown to contain an origin of replication that uses negative feedback
control to narrow the distribution of plasmid copy numbers across cells and reduce
the risk of plasmid loss during division [103, 104]. However, this alone is not suffi-
cient to maintain full stability. In light of these limitations, efforts have already been
made to re-use a variety of existing microbial machinery to ensure plasmid persistence
in more complex environments [105]. Successful alternatives have been demonstrated
with the use of post-segregational killing systems [106, 91], active-partitioning mech-
anisms [91, 107] and auxotrophy [108].
Toxin-antitoxin (TA) systems are a type of post-segregation killing mechanism that
consists of a self regulated fragment with two or more genes that separately encode for
a toxic protein and an equivalent antidote protein. The toxic protein is normally stable
and is not broken down quickly while the antidote is normally unstable and short-lived
[109]. Due to these dynamics, the presence of a TA cassette on a plasmid ensures that
only the daughter cell that possesses the plasmid survives after a cell undergoes division
(Figure 2.1). Whereas the toxin in the system is always a protein, the method of the
antitoxin distinguishes the two types of systems. Type I systems are found in E. coli
and other Gram-negative bacteria and comprise of a small cell membrane damaging
hydrophobic protein and an RNA antitoxin that inhibits protein translation. Type
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Figure 2.1: Toxin-antitoxin (TA) post-segregation killing (PSK) systems for plasmid
maintenance. A) Plasmid loss in a population without a PSK system. B) PSK system
maintaining a plasmid in a population by preventing the growth of daughter cells
without the plasmids. Red indicates toxic element and green indicates antidote.
II systems consist of an unstable antitoxin protein that neutralises the toxin through
proteic complex formation [110]. Over the last few decades, a number of systems have
been discovered and characterised from across a variety of microbes [105].
2.2 Toxin-antitoxin Systems
In order to improve the functionality and stability of plasmids in synthetic biology
approaches, researchers have incorporated TA systems into the design of synthetic
circuits for microbiota investigations.
Hok/sok is a type I system that originates from the parB locus of the E. coli
plasmid R1 and has been shown to be effective in its native E. coli as well as the
Gram-negative Pseudomonas putida [111] (Figure 2.2A). It is a bactericidal system
where the toxin leads to cell death. The use of Hok/sok was recently demonstrated
in EcN with the introduction of the TA system into a synthetic circuit that could
non-invasively detect and signal liver metastasis [91]. Surprisingly, the introduction
of the Hok/sok cassette was found to show hardly any improvement in the stability
of the constitutive luxCDABE reporter in vitro without antibiotic selection. However,
the presence of the Hok/sok system vastly improved plasmid retention of the reporter
construct during in vivo tumour experiments after administration of the engineered
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EcN strain. This retention was further improved with the addition of the alp active
partitioning system on the reporter construct [91].
Axe/txe is a type II system from the axetxe locus of the Gram-positive Enterococcus
faecium plasmid pRUM (Figure 2.2B). It is a bacteriostatic system where the toxin
prevents cell growth. The functionality of Axe/Txe in E. faecium was demonstrated
with the creation of a luminescent reporter that was stable without antibiotic selection
[112]. In addition, it was shown that axe/txe could be used to stabilise a lumines-
cent reporter in the closely related Gram-positive Enterococcus faecalis in vivo without
antibiotic selection for five days [113].
2.3 Bacteriocins
An alternative PSK system to TA are bacteriocins, which are bacterially secreted pro-
teins that have a bactericidal effect on either a narrow or broad spectrum of other
bacteria lacking immunity [114]. By secreting these antimicrobials, a plasmid-bearing
population is able to police the environment, preventing the growth of plasmid-free
cells. In comparison to the TA system, bacteriocins can maintain plasmids even with
mutational instability. Whereas a single mutation in the toxin on a TA plasmid would
remove the selective pressure in that cell, the selection with bacteriocins is maintained
via the surrounding cells. Regardless of whether they are able to produce the bacteri-
ocin, each cell still needs to encode the immunity gene on the plasmid to avoid death
[115]. Successful attempts have already been made to use bacteriocins, such as the
Lcn972 system, to stabilise plasmids in L. lactis [116]. In addition, the colicin A bac-
teriocin was also able to stabilise a plasmid in E. coli for up to 18 daily passages [115].
The microcin V system is encoded on conjugative plasmids in E. coli and consists of
a low molecular weight toxic bacteriocin, along with the genes for a transporter and
Figure 2.2: A) The 633bp Hok/sok system codes for a toxic protein (hok), RNA anti-
toxin (sok) and modulatory protein (mok) needed for hok translation. B) The 1791bp
proteic axe/txe system codes for a single toxic protein (txe) and antidote protein (axe).
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immunity protein (Figure 2.3) [114]. It does not undergo any post-translational modi-
fication and, as such, does not require any extra enzyme encoding genes. Furthermore,
it has been shown that EcN already carries two bacteriocin systems in its chromosome;
microcins H47 and M [117]. More recently, it was also shown that native bacteriocins
found in EcN were vital in mediating competition in the inflamed gut in a inter and
intraspecies manner [118].
Figure 2.3: The 4848bp microcin V (MCC) system consists of genes coding for a toxic
protein (cvaC), an immunity protein (cvi) and a transporter system (cvaA and cvaB).
2.4 Aims
Due to the fact that different types of TA and bacteriocin systems originate from
different species of prokaryotes and use different molecular mechanisms, there is no
consensus on which PSK system is most suitable for use in common laboratory strains
or commensal vector strains. In addition to this, the stability of the synthetic circuit
will also be affected by the ultimate in vivo destination of the commensal strain. The
integration of a PSK system into a commensal strain like EcN could pave the way for
effective tools in monitoring and engineering the intestinal microbiota.
This piece of work aimed to design, test and evaluate the functionality of a number
of different PSK systems in stabilising fluorescent and bioluminescent reporter circuits
in the probiotic EcN strain in vitro and in vivo. These PSK systems include:
1. The TA Hok/sok (HS) system derived from the parB locus of E. coli.
2. The TA Axe/Txe (AT) system derived from the pRUM plasmid of E. faecium.
3. The microcin V (MCC) bacteriocin system derived from E. coli.
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2.5 Materials and Methods
2.5.1 Media and Strains
Lysogeny broth (LB) media and agar was used during propagation and cloning of
bacteria. Assays were carried out in LB media and when antibiotic selection was
applied, kanamycin was used at 25µg/mL, erythromycin at 100µg/mL and gentamy-
cin at 10µg/mL. All DNA manipulations were performed in E. coli DH5α (NEB).
All sequences were confirmed via Sanger sequencing (Source Bioscience, UK). E. coli
Nissle 1917 (EcN) was provided by Prof. Ian Henderson (University of Birmingham,
UK). Chemically competent EcN strains were made using the same standard protocol.
Briefly, this involved diluting an overnight strain culture 1:100 into 50ml of fresh LB
media and grown at 37◦C in a shaking incubator to an OD540 of 0.25 to 0.3. The culture
was then chilled on ice for 15 minutes and then centrifuged for 10 minutes at 5000g
and 4◦C. The medium was then discarded and the cell pellet resuspended in 30ml of
cold 0.1M CaCl2 before being kept on ice for a further 30 minutes. This suspension
was then centrifuged for 10 minutes at 5000g and 4◦C. The supernatant was once again
removed and the cell pellet was resuspended in 3ml of cold 0.1M CaCl2 solution with
15% glycerol. The final cell suspension was then aliquoted and flash frozen before being
stored at -80◦C.
Initial fluorescent plasmid stability assays were performed in an EcN variant where
the mini-Tn7 transposon system was used to genomically integrate gentamycin res-
istance and constitutive DsRedExpress expression into the chromosome (EcN_Red).
Briefly, the Tn7 transposon inserts as a single copy into a specific site named att Tn7
which is conserved in most known bacteria and is classed as a neutral chromosomal
site where genomic integration should not affect the host [119]. The miniTn7 system
takes advantage of these unique characteristics and consists of a helper plasmid with
the transposition genes and a delivery plasmid with the Tn7 flanks and DNA insert of
choice. The delivery plasmid acts as a suicide vector and consists of an origin of replic-
ation that only allows transient propagation in the chosen bacteria. In light of this, the
delivery plasmid is eventually dropped from the strain and the genomic insert is only
found in the chromosome. Here, the pTNS1 helper plasmid [120] and the pUC18T-mini-
Tn7T-Gm-DsRedExpress delivery plasmid [121] were used to engineer EcN according
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to the specified electroporation protocol. Along with growth in gentamycin and visible
DsRedExpress expression, colony PCR was performed to confirm the Tn7 integration
into EcN to derive EcN_Red. However, it was eventually discovered that the EcN_Red
strain was ampicillin resistant, which implied that the integration was faulty and the
delivery plasmid was not dropped after integration as expected. Due to this discovery,
all final fluorescent plasmid stability assays were repeated and instead performed in EcN
with a genomically integrated erythromycin-resistant luxCDABE cassette (EcN_Lux)
(Dr Tal Danino from the Columbia University, USA)[91].
All luminescent plasmid stability assays in liquid culture and in animals models
were performed in E. coli Nissle 1917 (EcN).
2.5.2 Plasmids and Cloning Methods
Fluorescent plasmids were constructed from OXB20_GFP, a plasmid with a pUC high
copy origin-of-replication, a kanamycin resistance cassette, an empty multiple cloning
site (MCS) and a dasher GFP gene being constitutively expressed in high quantities
by the OXB20 promoter (Oxford Genetics, UK) (Figure 2.4). A strong promoter
and high copy origin of replication was chosen to maximise the metabolic burden of
the plasmid on the host. Using standard DNA manipulation methods, Hok/sok (633bp
fragment cut with HindIII and SacI from plasmid pKG1022 [111]) and Axe/Txe (1390bp
fragment cut with SacI and BamHI from plasmid pREG531 [95]) were ligated and
individually cloned into the multiple cloning site of OXB20_GFP to derive plasmids
OXB20_GFP_HS and OXB20_GFP_AT. In order to evaluate the TA systems against
other PSK mechanisms, these constructs were tested alongside the microcin V (MCC)
bacteriocin. Briefly, PCR was used to clone and attach compatible restriction enzyme
sites to the MCC system [122]. This was then ligated into to OXB20_GFP to derive
OXB20_GFP_MCC. Both EcN_Red and EcN_Lux were transformed individually
with these plasmids via heat-shock methods (Figure 2.5).
Luminescent plasmids were constructed from pSEVA246, a plasmid based on the
pSEVA format [123] with a ColE1 high copy origin-of-replication, a kanamycin resist-
ance cassette, an empty multiple cloning site (MCS) and a promoterless LuxCDABE
operon (Figure 2.4). The strong constitutive phelp promoter [124] was cloned upstream
of luxCDABE to drive expression and derive p24_help-Lux. The 1390bp axe/txe frag-
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Figure 2.4: Graphical representation of constitutive OXB20_GFP and constitutive
p24_help-Lux plasmids.
Figure 2.5: Table of strains and plasmids used throughout.
ment was digested from plasmid pREG531 [95] with SacI and BamHI and ligated into
the MCS of p24_help-Lux to derive plasmid p24_help-Lux_AT. The 633bp hok/sok
fragment was PCR amplified from plasmid pKG1022 [111] and cloned into the MCS of
p24_help-Lux with SacI and BamHI to derive p24_help-Lux_HS. The MCC system
[122] was ligated into into the MCS of p24_help-Lux with SacI and XbaI to derive
p24_help-Lux_MCC. EcN was transformed individually with these plasmids via heat-
shock methods (Figure 2.5).
2.5.3 Growth Rate Assays
Overnight cultures of each strain were grown in triplicates and diluted 1/1000 into
LB media. 200µL from each culture was then transferred into 6 wells of a shallow
polystyrene 96-well plate (Corning R©, Sigma-Aldrich, UK) and sealed with a Breathe-
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Easy sealing membrane (Sigma-Aldrich, UK). The plate was then grown in a shaking
POLARstar Galaxy microplate reader (BMG LABTECH, UK) at 37◦C for 20 hours
with OD540 readings taken every 10 minutes. Growth curves were fitted using a non-
parametric Gaussian process method [125].
2.5.4 Fluorescent Plasmid Stability Assays in Liquid Culture
Three colonies of each EcN_Lux_OXB20_GFP strain were picked from LB-agar plates
and grown in 5mls of LB media with kanamycin and erythromycin overnight at 37◦C
and 200RPM to create starter cultures with a 100% plasmid bearing population. Assays
were performed with LB in a sterile autoclaved 96-well deep square well (2.2mL) pol-
propylene plate. The 96-well plate was split into two replicate sections with a random
arrangement of wells to minimise contamination and growth variation (Figure 2.6).
Each strain had 3 independent replicates and 3 biological replicates. Wells in the first
section were filled with 500µL of LB media with erythromycin (100µg/mL) and wells in
the second section were filled with 500µL of LB with both erythromycin and kanamy-
cin. With erythromycin resistance integrated into the chromosome of EcN_Lux, the
use of the antibiotic would prevent external contamination while running the assay in
the absence of kanamycin. 1µL of overnight starter culture was then used to inoculate
each well from the respective strain to create passage 1. The plate was then sealed
with a System Duetz breathable silicon sandwich (EnzyScreen, The Netherlands) and
clamped down in a shaking incubator at 37◦C and 350RPM for 24 hours. Subsequent
passages were made by using a 8-channel pipet to transfer 1µL of overnight culture into
an identical sterile autoclaved 96-well deep square well plate with the same LB well
arrangement and grown in the same conditions as before. Plasmid stability was then
investigated by using the GFP marker expressed from the plasmids and flow cytometry
to calculate the proportion of plasmid-bearing population for each strain over a total of
37 passages. The initial plasmid stability assays performed in EcN_Red were carried
out in the same manner for 21 passages but with gentamycin instead of erythroymcin.
Flow Cytometry Analysis and Plotting
Flow cytometry was performed on an Attune NxT Acoustic Focusing Cytometer with
Attune NxT Autosampler (Thermo Fisher Scientific, UK). 1µL of the appropriate strain
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Figure 2.6: Plasmid stability assay with daily passages. Yellow indicates LB with just
erythromycin and orange indicates control wells containing LB with both erythromycin
and kanamycin. Optical density and GFP fluorescence was measured at each passage.
culture was transferred into 200µL of PBS in a shallow polystyrene 96-well plate. The
Attune NxT Autosampler was used to record 10,000 events for each sample with 4
washes between each. GFP was excited using the blue laser (488nm) and was de-
tected using a 530/30nm bandpass filter. In order to prevent operator bias associ-
ated with manual drawing of gates and speed up the analysis of samples, a compu-
tational pipeline called autoGate was developed by Alexander Fedorec in the Barnes
Lab (github.com/ucl-cssb/autoGate) to automate the gating of singlet bacteria while
excluding background debris and bacterial doublets. Briefly, the method fits mixture
models of one, two and three clusters to the forward-scatter versus side-scatter data.
Using integrated completed likelihood (ICL) [126], the number of clusters that best fits
the data is calculated and the cluster centred closest to the expected bacterial popu-
lation coordinate is taken. A linear model is then fit to the side-scatter-height versus
side-scatter-area data and points falling too far away are removed as cell doublets.
The levels of trimming are shown in Figure 2.7. Python was used for Gaussian process
fitting [125] and the ggplot2 package in R was used for plotting. Briefly, this involved ex-
panding on previously published models [127] to incorporate post-segregational killing
and using Bayesian methods to fit a model to the plasmid-loss data.
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Figure 2.7: autoGate clustering and trimming of flow cytometry data.
2.5.5 Luminescent Plasmid Stability Assays in Liquid Culture
Three colonies of each EcN_p24_help-Lux strain were picked from LB-agar plates
and grown in 5mls of LB media with kanamycin overnight at 37◦C and 200RPM to
create starter cultures with a 100% plasmid bearing population. The assays were then
performed with LB in a sterile autoclaved 96-well deep square well (2.2mL) polpropylene
plate. In line with the fluorescent assays, the 96-well plate was split into two replicate
sections with a random arrangement of wells to minimise growth variation (Figure 2.6).
Each strain had 3 independent replicates and 3 biological replicates. Wells in the first
section were filled with 500µL of LB media with no antibiotic and wells in the second
section were filled with 500µL of LB with kanamycin. Once the wells were filled, the
entire plate was exposed to UV light for 40 minutes in a custom built perspex chamber
to minimise contamination. 1µL of overnight starter culture was then used to inoculate
each well from the respective strain to create passage 1. The plate was then sealed
with a System Duetz breathable silicon sandwich (EnzyScreen, The Netherlands) and
clamped down in a shaking incubator at 37◦C and 350RPM for 24 hours. Subsequent
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passages were made by using a 8-channel pipet to transfer 1µL of overnight culture into
an identical sterile autoclaved 96-well deep square well plate with the same LB well
arrangement and grown in the same conditions as before. Plasmid stability was then
investigated at each passage by transferring 200µL from each culture into a shallow
polystyrene 96-well plate (Corning R©, Sigma-Aldrich, UK) and detecting luminescence
and OD410 in a POLARstar Galaxy microplate reader (BMG LABTECH, UK). ggplot2
package in R was used for plotting.
2.5.6 Luminescent Plasmid Stability Assays in vivo
These experiments involved using a tumour xenograft model where tumours were ini-
tiated by subcutaneous injection of 5x10 6 cells of a human colorectal cancer cell line
(LS174T) in 100µl of PBS per flank of 5 6-week-old female nude mice (NcrNu strain;
Taconic) and grown for 1 to 2 weeks until they reached a size of 5 to 10mm. Along with
a EcN_Lux strain as a control, individual EcN strains with p24_help-Lux, p24_help-
Lux_AT, p24_help-Lux_HS and p24_help-Lux_MCC were grown in LB with kana-
mycin until exponential phase, washed three times in sterile PBS and then injected in-
travenously at a dosage of 1x10 6 bacteria. After bacterial colonisation of the tumours,
animals were monitored daily via IVIS (IVIS 200, Caliper Life Sciences) to detect the
presence of the plasmid via bioluminescence. Briefly, this involved anaesthetising the
mice with isoflurane and imaging with an open filter on the auto-exposure setting.
After 7 days, each of the tumours were sterilely extracted and homogenised using a
tissue dissociator (Miltenyi), an aliquot of which was seeded on each of LB plates and
LB with kanamycin plates. The ratio was calculated by comparing the mean counts
of plasmid bearing colonies on LB plates and LB plates with kanamycin from each
tumour [91]. ggplot2 package in R was used for plotting. Statistical significance was
demonstrated by the Mann-Whitney U test with R.
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2.6 Results
In order to evaluate the ability of the Hok/sok, axe/txe and microcin V systems to
stabilise a synthetic gene circuit in different environments, the respective gene frag-
ments were independently cloned into the fluorescent OXB20_GFP plasmid and the
luminescent p24_help-Lux plasmid to derive a number of constructs (Figure 2.8). The
ability of the PSK systems to stabilise the fluorescent OXB20_GFP plasmids in liquid
culture were first characterised in the EcN_Red strain and then in the EcN_Lux strain.
The luminescent p24_help-Lux constructs were characterised in the EcN strain first in
liquid culture and then in an in vivo tumour mouse model.
Figure 2.8: A) Control OXB20_GFP plasmid, OXB20_GFP_AT plasmid stabilised
with the axe/txe system, OXB20_GFP_HS plasmid stabilised with the Hok/sok sys-
tem and OXB20_GFP_MCC plasmid stabilised with the microcin V system. B) Con-
trol p24_help-Lux plasmid, p24_help-Lux_AT plasmid stabilised with the axe/txe
system, p24_help-Lux_HS plasmid stabilised with the Hok/sok system and p24_help-
Lux_MCC plasmid stabilised with the microcin V system.
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2.6.1 Plasmid Stability Assays in EcN_Red with OXB20_GFP
The plasmid stability assays in EcN_Red were performed for 21 daily passages. Figure
2.9 shows that the EcN_Red_OXB20_GFP control plasmid started to drop from the
population after 7 daily passages without any antibiotic selection. The population was
completely plasmid free within 16 passages. The HS system showed a slight level of
stabilisation where the plasmid drop was delayed until 10 days. However, the AT and
MCC systems demonstrated complete plasmid stability until the end of the experiment
(Figure 2.9). At the end of the stability assay it was apparent that the EcN_Red
strain still harboured the delivery plasmid used in the transposon genome integration
method. The competition resulting from the presence of this plasmid in the strain
would have therefore impacted the level of plasmid loss observed in stability assays
and it was concluded that the assays must be repeated with a strain of EcN where the
correct genomic integration of markers were confirmed.
Figure 2.9: Plasmid loss curves of OXB20_GFP, OXB20_GFP_AT,
OXB20_GFP_HS and OXB20_GFP_MCC in EcN_Red over 21 daily passages
in the absence of antibiotic selection. Fraction of plasmid-bearing population was
calculated from flow cytometry data at each daily time point. Plasmid loss curves were
fitted to the data using a Bayesian model by Alexander Fedorec (Barnes Lab, UCL).
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2.6.2 Plasmid Stability Assays in EcN_Lux with OXB20_GFP
In light of the problems observed with the EcN_Red strain, the stability assays were
repeated in EcN with a genomically integrated erythromycin-resistant luxCDABE cas-
sette (EcN_Lux) [91]. The plasmid stability assay was performed for 37 daily passages
where in addition to GFP fluorescence readings, control measurements of optical dens-
ity and luminescence were also taken (Appendix, Figures 5.1 and 5.2). Figures 2.10
and 2.11 show that the EcN_Lux_OXB20_GFP control plasmid started to drop from
the population after 5 daily passages without any antibiotic selection. The population
was completely plasmid free within 12 passages. The HS system was able to stabilise
the constructs substantially, and except for one replicate, was completely plasmid free
by day 20. The MCC system also stabilised the construct but showed a more incon-
clusive set of results. A gradual level of plasmid loss was observed from day 21 onwards
but four out of nine replicates remained entirely plasmid-bearing up until day 37. The
presence of the OXB20_GFP_MCC plasmid in these strains at the end of the 37 day
experiment was confirmed by mini-preps (Appendix, Figure 5.4). In comparison to
the other systems, AT was able to completely stabilise the GFP construct throughout
the entire 37 day experiment (Figure 2.10). The presence of the OXB20_GFP_AT
plasmid in the strain at the end of the 37 day experiment was confirmed in all replicates
by mini-preps (Appendix, Figure 5.3). Data points missing at days 7,8 and 30-34 were
due to equipment failure on the flow cytometer. Data points missing at day 17 were
due to human error during culture passaging.
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Figure 2.10: Plasmid loss curves of OXB20_GFP, OXB20_GFP_HS,
OXB20_GFP_MCC and OXB20_GFP_AT in EcN_lux over 37 daily passages
in the absence of antibiotic selection. Fraction of plasmid-bearing population was
calculated from flow cytometry data at each daily time point. Plasmid loss curves (in
red) were fitted to the data using a Bayesian model by Alexander Fedorec (Barnes Lab,
UCL). Assays were carried out with erythromycin selection but not kanamycin. Blue
dots represent experimental medians and grey lines indicate individual experimental
replicates.
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Figure 2.11: Plate-reader GFP fluorescence of OXB20_GFP, OXB20_GFP_AT,
OXB20_GFP_HS and OXB20_GFP_MCC over 37 daily passages in the absence of
antibiotic selection. OXBK, ATK, HSK and MCCK indicate control wells grown with
both erythromycin and kanamycin that should be 100% plasmid-bearing. Ecn and ecnk
indicate negative controls. Numbers indicate biological replicates and colours indicate
technical replicates.
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PSK Mechanisms Impact Growth
Figure 2.12 shows that in comparison to the EcN_Lux control strain, all constructs
showed a significant impact on the growth rate of the chassis. In comparison to the
control OXB20_GFP plasmid, all three PSK plasmids demonstrated an additional
burden on the growth rates with higher lag times. This indicates that while the high
copy plasmid and strong GFP expression is particularly burdensome on the host strain,
the additional PSK cassette provides a further metabolic load.
Figure 2.12: Growth curves for all EcN_Lux strains fitted using Gaussian processes.
Top, estimated growth rates. Bottom, estimated lag times. N=3.
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2.6.3 Plasmid Stability Assays in EcN with p24_help-Lux
After characterising the TA systems with a GFP fluorescent reporter, further work
was carried out to investigate their plasmid stabilising capabilities with a LuxCDABE
reporter construct (p24_help-Lux). This would provide a higher metabolic burden
on the plasmid and create a reporter that could then subsequently be characterised
in vivo. The plasmid stability assay was performed for 14 daily passages where daily
luminescence and OD410 readings were taken. Figure 2.13 shows that the p24_help-
Lux control plasmid was completely dropped from the EcN population after 3 passages
without any antibiotic selection. Considering that even the positive kanamycin controls
eventually started to drop, it can be inferred that the high metabolic burden of the
reporter renders the plasmid unstable even with antibiotic selection. The HS system
was able to stabilise the constructs substantially but was completely plasmid free by
day 10. MCC also provided substantial stabilisation with two replicates still harbour-
ing the plasmid after 14 days. In comparison to the other systems, AT was able to
provide substantial stabilisation to the p24_help-Lux construct throughout the 14 day
experiment with only two replicates dropping (Figure 2.13). These findings mainly
corroborate with the differences found between the TA systems in the GFP constructs
(Figure 2.10).
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Figure 2.13: Plasmid stabilisation of p24_help-Lux with Axe/Txe, Hok/sok and MCC
in EcN over 14 daily passages in the absence of antibiotic selection. Luminescence of
p24_help-Lux was used to identify the plasmid bearing population from plate-reader
data at each daily time point. K replicate is positive kanamycin control.
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2.6.4 Stabilising Plasmids with PSK Systems in an in vivo Tumour
Model
With the TA systems demonstrating stabilisation of a luminescent reporter in liquid
culture without antibiotic selection (Figure 2.13), EcN strains containing either the
p24_help-Lux_AT, p24_help-Lux_HS, p24_help-Lux_AT or p24_help-Lux control
constructs were intravenously injected into a mouse tumour model for in vivo charac-
terisation.
Once administered, the EcN strain was shown to colonise the tumours in the mouse
flanks within 3 days (Figure 2.14). The tumours were then excised 7 days after injec-
tion and a colony count was performed from the homogenised tissue to independently
measure the stabilising effect of the Axe/Txe, Hok/sok and MCC systems on the re-
porter construct. Figure 2.14 shows that without any stabilising system, over 52% of
the population had dropped the p24_help-Lux plasmid after intravenous injection and
tumour colonisation. In comparison, the p24_help-Lux_AT was significantly stabil-
ised with nearly 92% of the population maintaining the plasmids after colonisation (p
< 0.0001). In comparison to the p24_help-Lux control, p24_help-Lux_HS was also
significantly stabilised with nearly 76% of the population maintaining the plasmids
after colonisation (p < 0.005). There was no significant difference between the plas-
mid fraction bearing population in p24_help-Lux and p24_help-Lux_MCC. While the
levels observed with Axe/Txe were higher, there was no significant difference between
the plasmid fraction bearing population in p24_help-Lux_AT and p24_help-Lux_HS.
In addition, variability was higher in the p24_help-Lux_HS constructs (Figure 2.14).
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Figure 2.14: PSK systems can stabilise the p24_help-Lux plasmid in EcN in vivo. Top,
representative IVIS images showing the luminescence of EcN_p24_help-Lux strains in
tumours of anaesthetised mice 3 days after intravenous injection. Bottom, compar-
ison of plasmid bearing population fraction after 7 days in excised tumours colonised
with a strain containing just the control p24_help-Lux (n=9 tumours) reporter plas-
mid and strains containing stabilised p24_help-Lux_AT (n=8 tumours), p24_help-
Lux_HS (n=7 tumours) and p24_help-Lux_MCC (n=5 tumours) plasmids. P values
were calculated using the Mann-Whitney U test. Single asterisk indicates p < 0.05 and
double asterisk indicates p < 0.005.
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2.7 Discussion
The use of PSK mechanisms for maintaining synthetic circuits in commensal strains like
EcN provide a valuable foundational tool for monitoring and engineering the intestinal
microbiome. While a large repertoire of systems exist, there is insufficient data on
their functionality and use in common laboratory strains or commensal vectors. Here
we successfully evaluate and compare the ability of a variety of TA and bacteriocin
PSK systems in stabilising synthetic reporter circuits in the absence of antibiotics in
both liquid culture and the in vivo environment.
The addition of the Axe/Txe cassette to plasmids provided substantial stabilisa-
tion. The AT system provided complete plasmid stability in both the EcN_Red and
EcN_Lux liquid culture experiments with the fluorescent OXB20_GFP plasmids (Fig-
ures 2.10 and 2.9). In addition, Axe/Txe was able to stabilise the luminescent
p24_help-lux plasmid for 14 days in liquid culture (Figure 2.13) and provide almost
complete plasmid retention during a 7 day in vivo tumour xenograft model (Figure
2.14). Interestingly, the Gram-positive E. faecium derived Axe/Txe system was found
to be more effective in EcN than the more widely characterised and used Hok/sok
system from E. coli. Furthermore, because Hok/sok is bactericidal and Axe/Txe is
only bacteriostatic, it would be expected that the static plasmid-free persister cells cre-
ated from the Txe toxin would begin to divide at a later passage and outcompete the
plasmid-bearing population. The Axe/Txe system is also found on pS177, another E.
faecium plasmid that also harbours the gene for vancomycin resistance [128]. A deeper
understanding of the mechanisms behind the Axe/Txe system could further elucidate
how clinically relevant multidrug-resistance strains of bacteria like E. faecium survive
and propagate. This may also lead to further tools in the fight against multi-drug res-
istance microbes. These findings demonstrate that the Axe/Txe system is an additional
and superior synthetic biology tool for maintaining plasmid stability than Hok/sok.
In line with published literature [91], the Hok/sok cassette provided a substantial
level of stability to both fluorescent and luminescent reporters in EcN strains dur-
ing liquid culture and in vivo experiments (Figures 2.9, 2.10 and 2.14). In the
EcN_Lux strain, it was able to delay the plasmid drop of OXB20_GFP by a further
20 days in comparison to the control. The earlier drop observed at 10 days passage
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with in EcN_Red could be due to the faulty presence of the pUC18T-mini-Tn7T-Gm-
DsRedExpress delivery plasmid providing further plasmid competition during growth
(Figure 2.9). While it was not as effective as the AT system in stabilising the p24_help-
lux plasmid in liquid culture, it functioned similarly in the in vivo tumour experiments.
It would enlightening to see how they compared in an experiment longer than 7 days.
The microcin V bacteriocin system was also successful in delaying the plasmid drop
in OXB20_GFP in both EcN_Red and EcN_Lux experiments (Figure 2.9). How-
ever, while it demonstrated near enough complete plasmid retention in EcN_Red, it
displayed much more variable results in the same experiment with the EcN_lux strain.
The form of the loss curves in Figure 2.10 between replicates suggests that the bacteri-
ocin killing system may be functioning variably. In addition, the bacteriocin cassette
did not offer a significant stablisation effect in vivo in comparison to the p24_help-lux
control (Figure 2.14). This raises interesting questions regarding the functionality of
the circuit and what environmental conditions favour it. Perhaps the bacteriocin was
washed away and concentrations were too low to provide effective cell killing in vivo.
2.8 Conclusions and Further Work
As set out in the aims, this piece of work demonstrated that is possible to use PSK
systems such as Hok/sok, Axe/Txe and microcin V to stabilise synthetic gene networks
in the probiotic EcN strain in the absence of antibiotic selection for up to 37 passages
in liquid culture. In addition, it was demonstrated that the Axe/Txe and Hok/sok sys-
tems could substantially stabilise a luminescent reporter plasmid in an in vivo tumour
xenograft model without antibiotic selection.
Whereas the stability provided by the Hok/sok system corroborates with previous
literature, the results in this piece of work demonstrate that Axe/Txe was a superior
plasmid stability system in EcN. The E. faecium derived Axe/Txe system was par-
ticularly effective in preventing a reporter plasmid dropping from the population. In
order to further characterise these systems, experiments could be repeated in other
commensal strains such as Salmonella typhimurium [129] or with different in vivo an-
imal models. While a tumour xenograft model was used here, it would be enlightening
to see how effective the PSK systems are in stabilising a genetic construct within a
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healthy or diseased intestine.
Collectively, these systems can act as foundational components to expand the ge-
netic repertoire of tools available for complex and robust investigations in both synthetic
biology and in vivo microbiota experiments.
52
3. Design and Construction of Therapeut-
ically Relevant Bacterial Sensors
3.1 Introduction
Billions of years of evolution has provided prokaryotes with a genome that allows them
to survive in almost any habitat found on earth. This repertoire of genes enable bac-
teria to sense and metabolise a wide variety of compounds and molecules. Synthetic
biologists utilise this expansive genome to develop novel synthetic circuits and expand
the genetic toolbox. One approach is to utilise bacterial promoters or repressors that
finely control the transcription of downstream genes. Building on this, a simple circuit
can be designed that can sense and respond to an input (see Section 1.3.3). This
linked output can be a fluorescent or luminescent reporter that can in turn be used to
qualitatively or quantitively measure the presence of an input. Whereas a large library
of well characterised inducible and constitutive promoters such as ParaBAD and PrecA
already exist, researchers are utilising the latest bioinformatics techniques to identify
and incorporate less well defined promoters from prokaryotes into genetic circuits for
novel functions [130].
While initial attempts set out to detect environmental toxins such as mercury, cad-
mium and lead [131, 132], researchers are now looking at the creation of therapeutically
relevant bacterial sensors. An example of this approach is reengineering an E. coli pro-
moter to detect and respond to gut inflammation [133]. The PNorR promoter is used
by several strains of E. coli to control the expression of nitric oxide reductases that
metabolise and detoxify nitric oxide. In a laboratory strain of E. coli, this promoter
was used to activate a fluorescent switch in response to biological nitric oxide in an in
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vitro inflammation model with inflamed mouse ileum explants. These approaches could
be coupled to a commensal vector to measure inflammation in vivo.
Another therapeutic bacterial sensor circuit enabled E. coli to sense and destroy
the pathogenic Pseudomonas aeruginosa [134, 135]. This approach involved placing the
quorum molecule sensing PLuxR promoter from P. aeruginosa upstream of the genes for
an E. coli E7 lysis protein and an antimicrobial bacteriocin. Upon detection of quorum
sensing molecules specific to P. aeruginosa, this strain undergoes lysis and releases
the antimicrobial bacteriocin into the immediate vicinity and destroys surrounding P.
aeruginosa.
3.2 Related Work
Reactive Nitrogen Species
Inflammatory bowel disease (IBD) consists of a group of conditions that are clinically
characterised by chronic inflammation of the colon and small intestines. It is estim-
ated to affect 2.5-3 million people in Europe alone and the most common variants are
ulcerative colitis and Crohn’s disease [136].
It is now thought that the chronic condition is caused by the host’s immune system
interacting pathologically to both genetic and environmental factors [88]. Differences
have long been observed in the microbial community structure of IBD patients in com-
parison to healthy controls. Luminal concentrations of reactive nitrogen species (RNS)
like nitrate, nitrite and nitric oxide are also known to be significantly increased in ulcer-
ative colitis [137]. More recently, it was shown that nitrate generated as a byproduct
of inflammation provided a significant growth advantage to certain strains of intest-
inal bacteria [138]. Due to the integral role of the intestinal microbiome in conditions
such as this, efforts have already been made to both broaden our understanding and
develop new tools for diagnosis and treatment. A recent example includes using an E.
coli promoter to detect and respond to gut inflammation [133]. The PNorR promoter
is used by several strains of E. coli to control the expression of nitric oxide reductases
that metabolise and detoxify nitric oxide. This promoter was used in a synthetic cir-
cuit, implemented within a laboratory strain of E. coli, to activate a fluorescent switch
in response to biological nitric oxide in an in vitro inflammation model with inflamed
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Figure 3.1: Regulation of the E. coli yeaR-yoaG operon by the NsrR repressor and the
NarX-NarL and NarQ-NarP two-component systems. NsrR represses gene expression
upon nitric oxide detection. NarX and NarQ is independently able to detect nitrate
and nitrite, respectively. Upon detection, they phosphorylate NarL and NarP which
interact with DNA to activate transcription of the operon.
mouse ileum explants.
As a facultative aerobe, E. coli K12 strains can use the yeaR-yoaG operon to switch
to respiratory nitrate ammonification to generate energy during anaerobic growth [139].
This tightly regulated system is known to control gene expression through a combina-
tion of the NsrR repressor and the Nar two-component system which is composed of the
NarX, NarQ, NarL and NarP proteins (Figure 3.1). While the nitric oxide-responsive
NsrR protein represses the transcription of the yeaR-yoaG operon, the NarX-NarL and
NarQ-NarP two-component system activates transcription upon independent nitrate
and nitrite detection.
Through the use of this PyearR promoter region, a team was recently able to create a
whole-cell biosensor capable of detecting increasing concentrations of nitrate in clinical
samples of serum and urine [90]. Furthermore, they incorporated integrase genes into
the sensor circuit that enabled them to create an amplifying switch circuit capable of
detecting lower thresholds of nitrate in urine and serum. These results show that by
coupling bacterial promoters with more complex genetic components developed through
synthetic biology, it is possible to increase the robustness of a circuit and in turn create
clinically relevant bacterial biosensors.
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Short Chain Fatty Acids
Short chain fatty acids (SCFAs) are microbial fermentation products from ingested
carbohydrates. Recent findings have indicated that SCFAs such as butyrate, propi-
onate and acetate have roles in several metabolic and inflammatory conditions such
as obesity, diabetes and IBD [140]. It is thought that these SCFAs directly act on
the surface exposed G protein-coupled receptors of the host cells in the lumen [42].
SCFA driven signalling interactions with these receptors have been found to mediate
anti-inflammatory outcomes by promoting the differentiation of regulatory T cells and
IL-10 producing T cells [141, 142]. It is hypothesised that these associations also me-
diate the protective effects of a high fibre diet on colorectal cancer [143]. The complex
interactions of the host’s diet and genetics with the intestinal microbiota means that
there are many mechanisms yet to be understood.
Based on the ability of some bacterial strains to detect and use propionate as a
sole carbon and energy source, a propionate inducible system (pPro) was identified
and characterised from the prpBCDE operons of E. coli and Salmonella enterica [144].
It was shown that after intake into the cell, propionate is activated to propionyl-CoA
by prpE-encoded propionyl-CoA synthetase. This is then catalysed to 2-methylcitrate
(2-MC) by the prpC -encoded 2-MC synthase. prpBD then produces enzymes that
convert 2-MC into pyruvate and succinate for energy production in the methylcitrate
cycle [145]. Eventually, it was understood that it was 2-MC, and not propionate, that
signals the presence of propionate in the environment as transcription is initiated by
2-MC-activated PrpR protein through the sigma-54 factor (Figure 3.2).
Alongside the prpR transcriptional activator gene, the PprpB promoter region was
used to create the pPro inducible expression system which was shown to be comparable
to existing systems based on promoters such as Ptac and Ptrc[145]. Upon induction with
50mM propionate, a maximum 1,500 fold induction of GFP expression was recorded
in strains such as E. coli BL21, MG1655 and W3110. However, the pPro system was
shown to be inactive in other strains such as E. coli DH5α and DH510B as they lack
the chromosomal prpBCDE operon and are therefore unable to produce the enzymes
needed for 2-MC production. In addition, it was noted that the supplementary presence
of carbon sources like glucose or glycerol in LB media would lead to catabolic repression
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Figure 3.2: Regulation of the E. coli prpBCDE operon by propionate and the regulatory
prpR protein. After intake into the cell, propionate is activated to propionyl-CoA by
prpE-encoded propionyl-CoA synthetase and then catalysed to 2-methylcitrate (2-MC)
by the prpC -encoded 2-MC synthase. prpBD then produces enzymes that convert
2-MC into pyruvate and succinate for energy production in the methylcitrate cycle.
Transcription is initiated by 2-MC-activated PrpR protein through the sigma-54 factor.
of the system upon propionate induction. This is a vital microbial process where the
bacteria adapt to inhibit the production of certain catabolic enzymes so that they can
carry on using preferred carbon sources like glucose that allow the fastest growth rates.
While the presence of glucose or glycerol inhibited pPro induction with propionate in
LB media, it was found to have a minor impact in supplemented M9 media [146]. The
pPro induction system can be further evaluated as a potential tool in elucidating the
link between SCFA metabolism and intestinal dysbiosis.
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pH
The intraluminal pH of the intestinal tract rapidly changes. The extremely acidic
conditions in the stomach give way to a pH of 6 in the duodenum which increases further
to pH 7.4 in the ileum. This then drops to pH 5.7 in the caecum before reaching pH 6.7
in the rectum [147]. More recently, the interlinked relationship between the microbiome
and pH of the niches they occupy have been under investigation in regards to conditions
such as acne [148] and bacterial vaginosis [149]. In order to provide some growth or
survival advantage in acidic conditions, the PcadC region of the cadBA operon in E.
coli activates transcription under external acidic pH and in the presence of lysine [150]
(Figure 3.3). Using β-galactosidase assays, it was shown that PcadC could significantly
increase expression when the pH was decreased from 7.6 to 5.4. A system like this
could be used to design a biosensor circuit to only activate in predetermined locations
or to detect dysbiotic pH at microbial niches within the intestines, skin and vagina.
Figure 3.3: Regulation of the E. coli cadBA operon by external pH and the positive
activator cadC. Under acidic conditions and in the presence of lysine, the cadC protein
acts as a positive regulator to initiate transcription of the operon through the PcadC
promoter region. The operon encodes a lysine-cadaverine antiporter (cadB) and a lysine
decarboxylase (cadA).
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Bile Acids
Secondary bile acids are formed from colonic bacteria metabolising the primary bile
acids that are synthesised by the liver. They are considered pro-inflammatory bacterial
metabolites and are thought to contribute to colorectal carcinogenesis through reactive
oxygen species (ROS) and RNS [41, 42, 43]. As well as higher levels of bile acids being
found in the faeces of patients with colorectal cancer [151], in vivo animal studies have
shown that the administration of bile acids results in a higher incidence of tumours
in the intestines [152]. In addition to their pro-inflammatory effects, these compounds
have also recently been associated with providing resistance to pathogenic Clostridium
difficile infection [44]. In relation to this, Bifidobacterium breve was found to encode
a bile-inducible membrane protein (BBr_0838) which provides the bacteria with toler-
ance against bile acids [153]. The putative promoter region of this membrane protein
could be harnessed for bile acid detection.
3.3 Aims
Advancements in sequencing and bioinformatic techniques have resulted in the iden-
tification of a large number of confirmed or putative regulatory regions that could be
used for de novo gene regulation.
By building on this extensive literature, this piece of work aimed to design, test and
evaluate a range of therapeutically relevant sensors in the probiotic EcN strain. This
included:
1. A sensor based on the yeaR-yoaG operon that can detect a range of RNS such
as nitric oxide, nitrate and nitrite.
2. A sensor based on the prpBCDE operon that can detect the SCFA propionate.
3. A sensor based on the cadBA operon that can detect changes in external pH.
4. A sensor based on the putative promoter region of the BBr_0838 gene that can
detect bile acids.
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3.4 Materials and Methods
3.4.1 Media and Strains
Lysogeny broth (LB) media and agar was used during propagation and cloning of
bacteria. Assays were carried out in M9 minimal media supplemented with 1mM
thiamine hydrochloride, 0.4% glycerol, 0.2% casamino acids, 2mM MgSO4 and 0.1mM
CaCl2. When antibiotic selection was applied, kanamycin was used at 25µg/mL and
ampicillin was used at 100µg/mL.
All DNA manipulations were performed in E. coli DH5α (NEB). All sequences were
confirmed via Sanger sequencing (Source Bioscience, UK). The bacterial nitric oxide
synthase producing pNOSBan plasmid [154] (Professor Evgeny Nudler from the New
York University School of Medicine, USA) was transformed into and expressed in E.
coli BL21 (DE3) (NEB). This strain was referred to as EcB_pNOSBan. Bacillus subtilis
168 was purchased from the Bacillus Genetic Stock Center (Ohio, USA).
All final induction assays were performed in E. coli Nissle 1917 (EcN) (Prof. Ian
Henderson from the University of Birmingham, UK). Chemically competent EcN was
made using standard protocols. Briefly, this involved diluting an overnight EcN LB
culture 1:100 into 50ml of fresh LB media and grown at 37◦C in a shaking incubator
to an OD600 of 0.25 to 0.3. The culture was then chilled on ice for 15 minutes and
then centrifuged for 10 minutes at 5000g and 4◦C. The medium was then discarded
and the cell pellet resuspended in 30ml of cold 0.1M CaCl2 before being kept on ice
for a further 30 minutes. This suspension was then centrifuged for 10 minutes at 5000g
and 4◦C. The supernatant was once again removed and the cell pellet was resuspended
in 3ml of cold 0.1M CaCl2 solution with 15% glycerol. The final cell suspension was
then aliquoted and flash frozen before being stored at -80◦C.
3.4.2 Plasmids and Cloning Methods
Sensor assay plasmids were constructed from the promoterless OG241_GFP plasmid
(Figure 3.4) which consisted of an upstream multiple cloning site, a dasher GFP
reporter gene, a pUC high copy origin-of-replication and a kanamycin resistance cas-
sette (Oxford Genetics, UK). Standard restriction enzyme and PCR cloning was used
throughout. As a positive control, the strong constitutive OXB19 promoter (Oxford
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Genetics, UK) was placed upstream of GFP to derive OXB19_GFP. The prpR-PprpB
region was cloned out by PCR from the pPro24-gfp plasmid [144] and ligated into the
MCS of OG241_GFP to derive pProE_GFP. The 100bp promoter region of the E.
coli yeaR/yoaG operon [155] was cloned out of the genomic DNA of E. coli DH5α by
PCR and ligated into the MCS of OG241_GFP to derive pYeaR_GFP. The 284bp
promoter region of the BBr_0838 gene from Bifidobacterium breve UCC2003 [153] was
synthesised as a gBlock Gene Fragment R© (IDT DNA, USA) and ligated into the MCS
of OG241_GFP to derive pBBr_GFP. The 672bp region of the cadBA operon identi-
fied as PCad600 [150] was cloned out of the genomic DNA of E. coli DH5α by PCR and
ligated into the MCS of OG241_GFP to derive pCadC_GFP. SnapGene was used to
simulate and plan ligation steps. EcN was transformed individually with these plasmids
via heat-shock methods to give the strains listed in Figure 3.5.
Figure 3.4: Graphical representation of promoterless OG241_GFP plasmid.
Strain Name Host Bacterium Plasmid Plasmid Source 
EcN_OG241_GFP E.coli Nissle 1917 OG241_GFP_pUC_Kan
R  
(promoterless control) Oxford Genetics, UK 
EcN_OXB19_GFP E.coli Nissle 1917 OXB19_GFP_pUC_Kan
R 
(constitutive control) This work 
EcN_pProE_GFP E.coli Nissle 1917 pProE_GFP_pUC_KanR This work 
EcN_pYeaR_GFP E.coli Nissle 1917 pYeaR_GFP_pUC_KanR This work 
EcN_pBBr_GFP E.coli Nissle 1917 pBBr_GFP_pUC_KanR This work 
EcN_pCadC_GFP E.coli Nissle 1917 pCadC_GFP_pUC_KanR This work 
EcB_pNOSBAN E.coli BL21 (DE3) pNOSBAN_AmpR Gusarov et al. [2008] 	
Figure 3.5: Table of strains used throughout.
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3.4.3 Induction Assays
All induction assays were performed over 16 hours at 37◦C and 350RPM at a volume
of 750µL in sterile autoclaved 96-well deep square well (2.2mL) polypropylene plates
(BRAND R©, Sigma-Aldrich, UK) sealed with Breathe-Easy sealing membranes (Sigma-
Aldrich, UK). Induction was calculated through flow cytometry analysis. Sodium
nitrate, sodium nitrite and sodium nitroprusside (SNP) was used to induce the pY-
eaR_GFP construct with nitrate, nitrite and nitric oxide, respectively [139, 133]. So-
dium propionate was used for investigating the pPro_GFP construct [144]. The pBBr
_GFP construct was induced with deoxycholic acid [153].
Concentration Range Induction Assays
Concentration range induction assays were performed by diluting triplicate overnight
cultures 1:500 into supplemented M9 media with the appropriate inducer concentration.
For induction assays in growing phase, overnight cultures were grown in triplicates and
diluted 1:500 into supplemented M9 media with the appropriate inducer. For induction
assays in stationary phase, overnight cultures were grown in triplicates and spun down
at 4000g before removing the supernatant and resuspending in fresh supplemented M9
media with the appropriate inducer.
pNOSBan and Bacillus subtilis Induction Assays
The pYeaR_GFP-pNOSBan liquid induction assay was performed by first removing the
supernatant of an overnight culture of EcB_pNOSBan induced at 2% arabinose and
2mM arginine but without any ampicillin. The assay was then performed in the same
manner of a concentration range induction but with varying proportions of pNOSBan
supernatant. The pYeaR_GFP-pNOSBan agar induction assay was performed by first
pipetting 80µL of uninduced EcN_pYeaR_GFP onto an antibiotic free LB agar plate
with 2% arabinose and 2mM arginine. The culture was spread evenly and left to dry
under a flame. The plate was then seeded at the outlined centre with 20µL of in-
duced overnight pNOSBan culture and again left to dry under a flame before being
left overnight at 37◦C. Inoculation loops were then used to collect EcN_pYeaR_GFP
samples at set distances from the outlined centre of the plate containing the induced
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pNOSBan strains. Induction was calculated by placing the inoculation loops into PBS
solution and analysing through flow cytometry. The control experiments consisted of
the same approach but with a plain LB agar plate and uninduced pNOSBan culture.
The EcN_pYear-B.subtilis induction assay was performed by first removing the super-
natant of an overnight culture of B.subtilis without any antibiotic. The assay was then
performed in the same manner of a concentration range induction but with varying
proportions of B.subtilis supernatant.
pH Sensor Assays
The pH sensor assay consisted of growing EcN_pCadC_GFP in media buffered to a
pH of either 5, 6, 7 or 8. This was done by first preparing sterile buffers with enough
physiological buffering capacity to maintain the pH of the media constant throughout
the culture growth. A bench top pH meter (HI-2211, HANNA Instruments) and either
1M HCl or 1M NaOH was used to create acetic acid (0.5M) buffered to pH 5, MES
(0.5M) buffered to pH 6, HEPES (0.5M) buffered to pH7 and HEPES (0.5M) buffered to
pH 8. The buffers were then sterilised through a 22µm filter and added individually to
1:500 diluted overnight culture of EcN_pCadC_GFP with kanamycin to create a final
culture at the desired pH (confirmed using the pH meter). All assays were performed
as before in a sealed 96-well deep square well plate over 16 hours at 37◦C and 350RPM.
The buffering capacity of the buffers and the pH of the overnight cultures were checked
using individual pH indicator strips (Whatman, Sigma-Aldrich, UK) (Figure 3.6).
Figure 3.6: Top: colour key indicating pH. Bottom: indicator strips showing the pH of
overnight EcN_pCadC_GFP culture buffered to pH 5, 6, 7, or 8 either in M9 or LB.
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3.4.4 Flow Cytometry Analysis and Plotting
Flow cytometry was performed on an Attune NxT Acoustic Focusing Cytometer with
Attune NxT Autosampler (Thermo Fisher Scientific, UK). 1µL of the appropriate strain
culture was transferred into 200µL of PBS in a shallow polystyrene 96-well plate. The
Attune NxT Autosampler was used to record 10,000 events for each sample with 4
washes between each one. GFP was excited using the blue laser (488nm) and was
detected using a 530/30nm bandpass filter. In order to prevent operator bias associ-
ated with manual drawing of gates and speed up the analysis of samples, a compu-
tational pipeline called autoGate was developed by Alexander Fedorec in the Barnes
Lab (github.com/ucl-cssb/autoGate) to automate the gating of singlet bacteria while
excluding background debris and bacterial doublets. Briefly, the method fits mixture
models of one, two and three clusters to the forward-scatter versus side-scatter data.
Using integrated completed likelihood (ICL) [126], the number of clusters that best fits
the data is calculated and the cluster centred closest to the expected bacterial popula-
tion coordinate is taken. A linear model is then fitted to the side-scatter-height versus
side-scatter-area data and points falling too far away are removed as doublets. The
levels of trimming are shown in Figure 3.7.
Figure 3.7: autoGate clustering and trimming of flow cytometry data.
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All plots were made using the flowCore and ggplot2 R packages. Non-linear least
squares (nls function in R) curve fitting was used to fit a line to induction plots. This
model approximates the non-linear function using a linear one and iteratively refines
the parameter values to the best fit. Locally weighted least square regression smoothing
(loess function in R) was used to fit lines on EcN growth curve plots. This uses a local
regression model fit to the points to create a smooth line. Relative fluorescent units
(RFU) were shown as mean averages along with the standard error of the mean. R was
also used for all statistics.
3.4.5 Growth Rate Assays
Overnight cultures were grown in triplicates and diluted 1:100 into supplemented M9
media with the appropriate inducer. A sterile autoclaved 96-well deep square well
(2.2mL) polypropylene plate (BRAND R©, Sigma-Aldrich, UK) was then filled with 16
replicates of 750µL of each culture. The plate was then sealed with a Breathe-Easy
sealing membrane (Sigma-Aldrich, UK) and grown at 37◦C and 350RPM for 16 hours.
While maintaining the membrane seal for the rest of the plate, 750µL from each strain-
culture was taken hourly and the OD600 was recorded on a tabletop WPA CO8000 Cell
Density Meter (Biochrom).
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3.5 Results
Biosensor circuits were designed and built using the promoterless OG241_GFP plasmid
to enable evaluation through fluorescent reporting (Figure 3.8). The propionate indu-
cible pPro system (containing the prpR transcriptional activator gene and the PprpB
promoter region from E. coli) was cloned into OG241_GFP to derive pProE_GFP
[144]. Likewise, the promoter region of the yeaR-yoaG operon was used to derive
the nitrate, nitrite and nitric oxide inducible pYeaR_GFP [139]. The promoter re-
gion of the Bbr-0838 gene was cloned in the attempt to derive the bile acid inducible
pBBR_GFP [153]. Lastly, the PcadC region of the cadBA operon was used to derive
the pH sensitive pCadc_GFP [150]. All sensors were characterised in the probiotic
EcN strain unless otherwise stated.
Figure 3.8: Plasmid maps of GFP based reporter sensors. A) Promoterless
OG241_daGFP plasmid. B) pProE_GFP propionate sensor. C) pYeaR_GFP nitrate,
nitrite and nitric oxide sensor. D) pBBR_GFP bile acid sensor. E) pCadC_GFP pH
sensor.
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3.5.1 EcN_pProE_GFP - Propionate Inducible Sensor
Figures 3.9 and 3.10 show that the EcN_pProE_GFP sensor demonstrated robust
induction over a wide range of propionate concentrations in both supplemented M9 and
LB media. In comparison to the maximum fold increase of 19.7 (from 478±84 RFU to
9403±747 RFU) in LB media, the maximum fold increase in supplemented M9 media
was 31.4 (from 204±3 RFU to 6510±568 RFU) at 200mM of inducer.
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Figure 3.9: EcN_pProE_GFP induction with propionate in supplemented M9 media.
Top: histogram density plot of GFP fluorescence after 16 hours induction. Bottom:
median GFP fluorescence after 16 hours induction. Flow cytometry data with 10,000
events (n=3).
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While a higher level of expression was observed in LB at the maximum induction
of 200mM propionate, the difference in fold increase was due to a significantly lower
average basal expression in supplemented M9 media (204±3 RFU) than in LB (478±84
RFU). The small population of uninduced cells at 100mM and 200mM could be persister
cells that have dropped the plasmid (Figure 3.10).
19.6
Figure 3.10: EcN_pProE_GFP induction with propionate in LB media. Top: histo-
gram density plot of GFP fluorescence after 16 hours induction. Bottom: median GFP
fluorescence after 16 hours induction. Flow cytometry data with 10,000 events (n=3).
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Figure 3.11 shows that the concentration of propionate only started having a
demonstrable impact on the overnight growth of EcN_pProE_GFP in supplemented
M9 media above 10mM. In order to investigate the toxicity of higher concentrations of
propionate at which significant levels of induction were observed, a time-course growth
assay was conducted with no inducer, 50mM or 100mM propionate (Figure 3.12).
Figure 3.11: EcN_pProE_GFP growth in increasing concentration of propionate in
supplemented M9 media after 16 hours (n=3).
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Figure 3.12: EcN_pProE_GFP growth over time with 0M, 50mM or 100mM propion-
ate in supplemented M9 media (n=3).
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In order to investigate the dynamic response of EcN_pProE_GFP, a time-course
induction with propionate was carried out in supplemented M9 media. The uninduced
control showed some basal expression over time before eventually plateauing (Appendix,
Figure 5.5). Figures 3.13 and 3.14 show that at both 50mM and 100mM propionate,
a rapid response was observed with a large proportion of the population becoming
induced within 1 or 2 hours.
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Figure 3.13: Time course EcN_pProE_GFP induction in supplemented M9 media with
50mM propionate over 16 hours. Top: histogram density plot of GFP fluorescence over
16 hours. Bottom: median GFP fluorescence over 16 hours induction. Flow cytometry
data with 10,000 events (n=3).
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Figure 3.14: Time course EcN_pProE_GFP induction in supplemented M9 media with
100mM propionate over 16 hours. Top: histogram density plot of GFP fluorescence
after 16 hours. Bottom: median GFP fluorescence over 16 hours induction. Flow
cytometry data with 10,000 events (n=3).
71
3.5.2 EcN_pYeaR_GFP - Nitrate, Nitrite and Nitric Oxide Indu-
cible Sensor
Figures 3.15, 3.16 and 3.17 show that the EcN_pYeaR_GFP sensor demonstrated
robust induction with nitrate, nitrite and nitric oxide in supplemented M9 media. A
maximum fold increase of 19.8 (from 459±32 RFU to 9106±552 RFU) was observed in
100mM nitrate, 11.1 (from 439±18 RFU to 5139±998 RFU) in 25mM nitrite and 14.1
(from 458±32 RFU to 6782±385 RFU) in 1mM SNP (nitric oxide donor).
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Figure 3.15: EcN_pYeaR_GFP induction with nitrate in supplemented M9 media.
Top: histogram density plot of GFP fluorescence after 16 hours induction. Bottom:
median GFP fluorescence after 16 hours induction. Flow cytometry data with 10,000
events (n=3).
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Figure 3.16: EcN_pYeaR_GFP induction with nitrite in supplemented M9 media.
Top: histogram density plot of GFP fluorescence after 16 hours induction. Bottom:
median GFP fluorescence after 16 hours induction. Flow cytometry data with 10,000
events (n=3). Density plots at higher concentrations showed some uncharacteristic
curves. This was most likely due to the toxicity of increasing levels of nitrite.
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Figure 3.17: EcN_pYeaR_GFP induction with SNP (nitric oxide donor) in supple-
mented M9 media. Top: histogram density plot of GFP fluorescence after 16 hours
induction. Bottom: median GFP fluorescence after 16 hours induction. Flow cyto-
metry data with 10,000 events (n=3). The small population of uninduced cells at
7.5mM could be persister cells that have dropped the plasmid or dead cells.
74
The EcN_pYeaR_GFP sensor also showed induction with nitrate, nitrite and nitric
oxide in LB media (Figure 3.18, 3.19 and 3.20). A maximum fold increase of 44.7
(from 595±17 RFU to 26597±5780 RFU) was observed in 75mM nitrate, 31.9 (from
548±4 RFU to 17467±1743 RFU) in 100mM nitrite and 46.9 (from 542±57 RFU
to 25431±1850 RFU) in 100mM SNP (nitric oxide donor). These were significantly
higher in comparison to induction in M9 media and was mostly due to the inability
of EcN_pYeaR_GFP to tolerate higher inducer concentrations when grown in supple-
mented M9 media (Figure 3.21).
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Figure 3.18: EcN_pYeaR_GFP induction with nitrate in LB media. Top: histogram
density plot of GFP fluorescence after 16 hours induction. Bottom: median GFP
fluorescence after 16 hours induction. Flow cytometry data with 10,000 events (n=3).
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Figure 3.19: EcN_pYeaR_GFP induction with nitrite in LB media. Top: histogram
density plot of GFP fluorescence after 16 hours induction. Bottom: median GFP
fluorescence after 16 hours induction. Flow cytometry data with 10,000 events (n=3).
Density plots at higher concentrations showed some uncharacteristic curves. This was
most likely due to the toxicity of increasing levels of nitrite.
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Figure 3.20: EcN_pYeaR_GFP induction with SNP (nitric oxide donor) in LB media.
Top: histogram density plot of GFP fluorescence after 16 hours induction. Bottom:
median GFP fluorescence after 16 hours induction. Flow cytometry data with 10,000
events (n=3).
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Figure 3.21 shows that the RNS inducers started becoming toxic to EcN_pYeaR_GFP
in supplemented M9 media at various different concentrations. In order to investigate
the toxicity of higher concentrations of inducer at which significant levels of induc-
tion was observed, a time-course growth assay was conducted with no inducer, 25mM
nitrate, 7.5mM nitrite and 250µM SNP (Figure 3.22).
Figure 3.21: EcN_pYeaR_GFP growth with increasing concentrations of nitrate, ni-
trite or SNP (nitric oxide donor) in supplemented M9 media after 16 hours (n=3).
0
1
2
3
4
0 2 4 6 8 10 12 14 16
Time (Hours)
OD
60
0
Uninduced Control
25mM Nitrate
7.5mM Nitrite
250uM SNP
EcN_pYear Growth in M9 Media
Figure 3.22: EcN_pYeaR_GFP growth over 16 hours with no inducer, 25mM nitrate,
7.5mM nitrite or 250µM SNP (nitric oxide donor) in supplemented M9 media (n=3).
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EcN_pYeaR_GFP - Time-course Induction
In order to investigate the dynamic response of EcN_pYeaR_GFP, a time-course in-
duction with the various inducers were carried out in supplemented M9 media in
either the growing or stationary phase. Figure 3.23 shows that at 50mM nitrate,
EcN_pYeaR_GFP demonstrated rapid induction within 2 to 3 hours during the sta-
tionary phase of growth. In comparison, induction was considerably slower during the
growth phase where it took 5 to 6 hours (Figure 3.24).
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Figure 3.23: Time course EcN_pYeaR_GFP induction during the stationary phase in
supplemented M9 media with 50mM nitrate over 16 hours. Top: histogram density plot
of GFP fluorescence over 16 hours. Bottom: median GFP fluorescence over 16 hours
induction. Stationary phase indicates an overnight culture spun down and resuspended
in fresh media before being induced. Flow cytometry data with 10,000 events (n=3).
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However, even though induction was slower, EcN_pYeaR_GFP reached a higher
level of induction during the growth phase experiment with half the concentration of
nitrate (25mm compared to 50mM).
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Figure 3.24: Time course EcN_pYeaR_GFP induction during the growing phase in
supplemented M9 media with 25mM nitrate over 16 hours. Top: histogram density
plot of GFP fluorescence over 16 hours. Bottom: median GFP fluorescence over 16
hours induction. Growing phase indicates an overnight culture that was diluted 1:500
in fresh media before being induced. Flow cytometry data with 10,000 events (n=3).
80
Figure 3.25 shows that at 15mM nitrite, EcN_pYeaR_GFP demonstrated rapid
induction within 2 hours during the stationary phase of growth. Induction during the
growth phase was just as rapid in 7.5mM nitrite (Figure 3.26).
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Figure 3.25: Time course EcN_pYeaR_GFP induction during the stationary phase in
supplemented M9 media with 15mM nitrite over 16 hours. Top: histogram density plot
of GFP fluorescence over 16 hours. Bottom: median GFP fluorescence over 16 hours
induction. Stationary phase indicates an overnight culture spun down and resuspended
in fresh media before being induced. Flow cytometry data with 10,000 events (n=3).
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Figure 3.26: Time course EcN_pYeaR_GFP induction during the growing phase in
supplemented M9 media with 7.5mM nitrite over 16 hours. Top: histogram density
plot of GFP fluorescence over 16 hours. Bottom: median GFP fluorescence over 16
hours induction. Growing phase indicates an overnight culture that was diluted 1:500
in fresh media before being induced. Flow cytometry data with 10,000 events (n=3).
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Figure 3.27 shows that at 500µM SNP nitrate, EcN_pYeaR_GFP demonstrated
rapid induction within 2 to 3 hours during the stationary phase of growth. In compar-
ison, induction was considerably slower during the growing phase at 250µM SNP where
it took 6 to 8 hours (Figure 3.28).
Figure 3.27: Time course EcN_pYeaR_GFP induction during the stationary phase in
supplemented M9 media with 500µM SNP (nitric oxide donor) over 16 hours. Top:
histogram density plot of GFP fluorescence over 16 hours. Bottom: median GFP
fluorescence over 16 hours induction. Stationary phase indicates an overnight culture
spun down and resuspended in fresh media before being induced. Flow cytometry data
with 10,000 events (n=3).
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Figure 3.28: Time course EcN_pYeaR_GFP induction during the growing phase in
supplemented M9 media with 250µM SNP (nitric oxide donor) over 16 hours. Top:
histogram density plot of GFP fluorescence over 16 hours. Bottom: median GFP
fluorescence over 16 hours induction. Growing phase indicates an overnight culture
that was diluted 1:500 in fresh media before being induced. Flow cytometry data with
10,000 events (n=3).
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EcN_pYeaR_GFP - Induction with Bacterial Nitric Oxide Synthase
Through the use of pNOSBan, it was demonstrated that EcN_pYeaR_GFP could also
detect RNS direct from bacterial sources. Once induced, pNOSBan expresses the gene
for bacterial nitric oxide synthase (NOS) from Bacillus anthracis [154]. The cluster
of genes converts arginine into nitric oxide which due to its unstable nature is rapidly
broken down into nitrate and nitrite. E. coli BL21 was transformed with pNOSBan to
derive EcB_pNOSBan and induced overnight with 2% arabinose and 2mM arginine as
described previously [154].
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Figure 3.29: EcN_pYeaR_GFP induction with different proportions of induced
EcB_pNOSBan supernatant in supplemented M9 media. Top: histogram density plot
of GFP fluorescence after 16 hours induction. Bottom: median GFP fluorescence after
16 hours induction. Flow cytometry data with 10,000 events (n=3).
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Figure 3.29 shows that in supplemented M9 media, EcN_pYeaR_GFP demon-
strated a 3.5 fold increase in GFP fluorescence with 50% EcB_pNOSBan supernatant
(from 336±24 RFU to 1187±101 RFU). In LB media, this was increased to a 20.1 fold
increase (from 264±6 RFU to 5302±2441 RFU) (Figure 3.30).
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Figure 3.30: EcN_pYeaR_GFP induction with different proportions of induced
EcB_pNOSBan supernatant in LB media. Top: histogram density plot of GFP fluor-
escence after 16 hours induction. Bottom: median GFP fluorescence after 16 hours
induction. Flow cytometry data with 10,000 events (n=3).
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As B. subtilis 168 also contains a NOS variant, a similar assay was conducted to
see whether EcN_pYeaR_GFP could detect RNS from the overnight supernatant of a
B. subtilis 168 culture. In LB, EcN_pYeaR_GFP demonstrated a 2.5 fold increase in
GFP fluorescence with 50% B. subtilis 168 supernatant (from 213±1 RFU to 539±111
RFU) (Figure 3.31).
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Figure 3.31: EcN_pYeaR_GFP induction with different proportions of Bacillus subtilis
168 supernatant in LB media. Top: histogram density plot of GFP fluorescence after
16 hours induction. Bottom: median GFP fluorescence after 16 hours induction. Flow
cytometry data with 10,000 events (n=3).
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The ability of EcN_pYeaR_GFP to detect RNS from EcB_pNOSBan was also in-
vestigated on an agar co-culture plate (Figure 3.32). A qualitative difference could be
seen in the level of GFP fluorescence on an agar plate grown with induced EcB_pNOSBan
in comparison to the uninduced control (Figure 3.33).
Figure 3.32: Graphical representation of the EcN_pYeaR_GFP - EcB_pNOSBan agar
induction assay demonstrating the induced EcB_pNOSBan (at the centre) producing
nitrates, nitrites and nitric oxide to induce the EcN_pYeaR_GFP lawn grown overnight
on the agar plate.
Figure 3.33: Photograph of the EcN_pYeaR_GFP-EcB_pNOSBan agar induction as-
say under UV illumination. Left: EcN_pYeaR_GFP grown overnight with induced
EcB_pNOSBan seeded at the centre of the plate. Right: EcN_pYeaR_GFP grown
overnight with uninduced EcB_pNOSBan seeded at the centre of the plate. Images
were taken side by side at the same time.
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This GFP expression was quantified with flow cytometry as a measure of distance
from the centre of the plate. Figure 3.34 shows that at 0mm from the induced
EcB_pNOSBan centre, GFP expression from EcN_pYeaR_G was 7415±797 RFU. This
decreased to 4926±125 RFU and 1723±438 RFU at a distance of 15mm and 30mm
from the centre, respectively. No demonstrable differences were seen from the basal ex-
pression on the control plate with uninduced EcB_pNOSBan at the centre (Appendix,
Figure 5.6).
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Figure 3.34: EcN_pYeaR_GFP induction on an agar plate at different distances from
the induced pEcB_pNOSBan centre. Top: histogram density plot of GFP fluorescence
after 16 hours growth. Bottom: median GFP fluorescence after 16 hours growth. Flow
cytometry data with 10,000 events (n=3).
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3.5.3 EcN_pCadC_GFP - pH Sensor
Figures 3.36 and 3.35 shows that the EcN_pCadC_GFP sensor demonstrated the
ability to induce GFP expression at a lower pH in LB but not in supplemented M9
media. After overnight growth in LB media buffered to pH 8 and 7, GFP expression
was at 217±39 RFU and 547±64 RFU, respectively. In LB media buffered to pH 6
and 5, this increased to 2790±170 RFU and 2895±393 RFU, respectively. This results
in a 13.3 fold increase from pH 5 to pH 8. These increases were not observed in the
EcN_OG241_GFP and EcN_OXB19_GFP controls (Appendix, Figure 5.7 and 5.8).
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Figure 3.35: EcN_pCadC_GFP induction after 16 hours in supplemented M9 media
buffered to pH 5 (with acetic acid), pH 6 (with MES), pH 7 (with HEPES) and pH 8
(with HEPES). Top: histogram density plot of GFP fluorescence after 16 hours growth.
Bottom: median GFP fluorescence after 16 hours growth. Flow cytometry data with
10,000 events (n=3).
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Figure 3.36: EcN_pCadC_GFP induction after 16 hours in LB media buffered to pH
5 (with acetic acid), pH 6 (with MES), pH 7 (with HEPES) and pH 8 (with HEPES).
Top: histogram density plot of GFP fluorescence after 16 hours growth. Bottom:
median GFP fluorescence after 16 hours growth. Flow cytometry data with 10,000
events (n=3).
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3.5.4 EcN_pBBr_GFP
Figure 3.37 shows that even though a slight increase in GFP expression was observed
with increasing concentrations of deoxycholic acid inducer, the EcN_pBBr_GFP con-
struct did not demonstrate a feasible level of induction as it had an extremely high
level of basal expression (22,911±973 RFU). The EcN_pBBr_GFP construct was also
tested with cholate but no induction was observed (data not shown).
1 2 3 4 5 6
0
1
2
3
4
log10(RFU)
De
ns
ity
0M Deoxycholic Acid
10uM
100um
1mM
A)
Deoxycholic Acid (M)
RF
U
0
15
00
0
30
00
0
45
00
0
0 10-5 10-4 10-3
B)
1 2 3 4 5 6
0
1
2
3
4
log10(RFU)
De
ns
ity
0M Deoxycholic Acid
10uM
100um
1mM
A)
Deoxycholic Acid (M)
RF
U
0
15
00
0
30
00
0
45
00
0
0 10-5 10-4 10-3
B)
Figure 3.37: EcN_pBBr_GFP induction with deoxycholic acid in LB media. Top:
histogram density plot of GFP fluorescence after 16 hours induction. Bottom: median
GFP fluorescence after 16 hours induction. Flow cytometry data with 10,000 events
(n=3).
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3.6 Discussion
Quantitatively detecting markers of interest through inducible reporter systems can
enable the design of more complex therapeutic circuits. The ability of EcN to occupy
various niches in the intestines means it is particularly relevant to the detection of
dysbiotic markers in the gut. Here it was shown that various inducible systems were
successfully characterised in the probiotic EcN strain for the first time.
The pPro inducible system has thus far been characterised in laboratory strains such
as E. coli BL21 (DE3) [144]. As EcN contains the required prpBCDE operon in the
chromosome (confirmed using the complete genome [87] via NCBI Blast alignment),
we were able to demonstrate the system working successfully for the first time in a
probiotic bacterial strain. EcN_pProE_GFP was able to robustly detect propionate
at a range of concentrations in both supplemented M9 and LB media (Figure 3.9 and
3.10). While the maximum induction fold increases observed here in LB were lower than
in the published pPro system (19.7 with EcN_pProE_GFP in 200mM compared to
15000 with pPro in 50mM) this could be due to the fact that the high copy (500) OG241
plasmid would have a considerably higher basal expression level than the low copy (20)
pBAD24 plasmid used in pPro [144]. The lower basal expression level observed in
supplemented M9 media (204±3 RFU compared to 478±84 RFU) increased the fold
change to 31.4 (Figure 3.9). This lower basal expression level in supplemented M9
media corresponds to previous reports of catabolic repression in LB media with the S.
enterica variant of the pPro system [146]. Nonetheless, EcN_pProE_GFP showed a
high level of GFP fluorescence at maximum induction in both M9 (6510±568 RFU) and
LB media (9403±747 RFU). The rapid level of induction observed also corresponds to
published reports on the system where significant fluorescence was recorded within 90
minutes [144] (Figure 3.13 and 3.14). It is thought that the system evolved for rapid
induction in order to enable the host to quickly adapt to carbon sources. In previous
reports investigating the effect of diet on SCFA levels in fecal matter, it was shown that
the concentration of this particular SCFA ranges from 12mM to 25mM [156, 157]. In
light of this, EcN_pProE_GFP could be used with in vivo models to elucidate the role
of SCFAs in diet, dysbiosis and host genetics. It could also be used to design circuits
that can sense low levels of propionate during pathologies and respond to normalise
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them by inducing the production of catabolic enzymes.
Using EcN_pYeaR_GFP, it was shown that a range of concentrations of nitrate,
nitrite and nitric oxide could be detected with a probiotic strain in both M9 and LB
media (Figure 3.15 to 3.20). Previous investigations showed that levels of nitrate can
rise to around 500µM at the mucosal layer of the intestines in an inflammation model
[138]. In another experiment, it was shown that stool nitrite levels were significantly
higher in children with IBD in comparison to healthy controls (162±31 mM vs 77±22
mM) [158]. In comparison to control patients with rectal levels of of nitric oxide at
around 2-3µM, patients suffering from Crohn’s disease were shown have nitric oxide
levels of 25-30µM [159]. As nitric oxide is rapidly degraded, higher levels are expected
to be found in the microenvironment surrounding inflamed intestinal tissue. In light
of this, EcN_pYeaR_GFP could be used to detect physiologically relevant levels of
nitrate, nitrite and nitric oxide directly from the intestines or stool samples. Through
the use of pNOSBan, it was also demonstrated that EcN_pYeaR_GFP could detect
RNS directly from bacterial sources in both M9 and LB (Figure 3.29 and 3.30).
As it was also shown that EcN_pYeaR_GFP could be induced from other bacterial
strains on an agar plate (Figure 3.34), the sensor could be further investigated as a
communication system with a sensor colony node harbouring the pYeaR plasmid and
an effector colony node harbouring the NOS plasmid.
Previously published work on a PyearR-GFP sensor only involved characterisation
with nitrate and clinical samples of serum and urine [90]. The findings presented here
with nitrate and EcN_pYeaR_GFP closely corroborate the minimal detection levels
and maximum fold increases previously published. In line with their work, nitrate was
detected from 1mM onwards and demonstrated a 10 fold increase at 10mM in both M9
and LB. It is worth noting that the induction was amplified by 10 fold with the use
of integrase genes to create a pYeaR-switch [90]. The work here builds further on our
understanding of PyearR through characterisation with nitric oxide and nitrite.
As discussed previously, a synthetic switch circuit was also used to detect intestinal
inflammation through the nitric oxide sensitive promoter region of the norV gene [133].
As this construct was solely characterised through a fluorescent switch inversion system,
a comparison cannot be made with EcN_pYeaR_GFP in terms of fold increase with
SNP (nitric oxide) induction. Due to the use of the norV promoter region, the circuit
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designed was only sensitive to nitric oxide and not to nitrate or nitrite. However, it
would be inquisitive to use a similar inflamed mouse ileum explant to investigate the
ability of EcN_pYeaR_GFP to detect biological inflammation. More recently, EcN was
engineered with a thiosulfate and a tetrathionate sensor to detect colonic inflammation
in a in vivo mouse model both in the presence or absence of oxygen [160]. While they
were able to use fluorescence as an output to detect inflammation in the feces and colon
with the thiosulfate sensor, they were unable to detect significant differences with the
tetrathionate sensor. This indicates that EcN_pYeaR_GFP would need a low enough
detection limit to work in a similar in vivo mouse model. Genetic amplification switches
could be used to achieve this [90].
It was demonstrated that EcN_pCadC_GFP could successfully induce GFP ex-
pression at a lower pH in LB but not in supplemented M9 media (Figure 3.36 and
3.35). The 13.3 fold increase observed here from pH 8 to pH 5 corresponds well to
the previously reported 12.5 fold increase observed with the pCadC_lacZ construct
in E. coli MC4100 [150]. While it was previously reported that the pCadC region
is dependent on exogenous lysine to mediate induction, this was not the case with
EcN_pCadC_GFP as induction was not affected in the presence or absence of 10mM
lysine. In addition, the fact that EcN_pCadC_GFP did not function in supplemented
M9 media (with or without lysine) indicates that the pCadC region could be depend-
ent on another exogenous compound for induction. The incorporation of a pH sensitive
system like this into a strain such as EcN could enable the design of a chassis that can
exploit the pH gradient of the intestines. For example, EcN could be designed to only
induce a gene when it is in a low pH niche. In addition, the system could be used to
either induce or suppress induction of an output gene when it detects a decreasing pH.
The EcN_pBBr_GFP sensor created with the promoter region of the BBr_0838
gene from B. breve UCC2003 [153] did not function as an induction system. While a
slight increase was observed with increasing levels of deoxycholic acid (Figure 3.37)
and cholate (data not shown), the system showed an extremely high basal expression
level. This is in contradiction with previously published work that showed the promoter
region increasing expression of GusA by 8 fold in B. breve using the pNZ272 promoter
probe vector [153]. This discrepancy is most likely due to the fact that the pBBr region
was characterised here in EcN instead of B. breve. The suitability of the pBBr region
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could be further analysed using bioinformatic tools such as PromoterHunter [161].
The ability to quantitively measure therapeutically relevant markers such as SCFA,
pH and RNS could shed light onto mechanisms behind dysbiosis in the gut. Through
the use of commensal vectors like EcN, precise in vivo models with mice or C. elegans
could be used to investigate the role of the intestinal microbiome in host genetics, diet
and pathologies. As well as monitoring the microbiota, these sensor components could
eventually be coupled to other genes to design and create dynamic genetic circuits with
pre-determined and responsive functions.
3.7 Conclusions and Further Work
As set out in the aims, this piece of work demonstrated that is possible to design and
characterise a range of therapeutic sensors using the probiotic EcN.
Elements from the E. coli yeaR-yoaG operon were successfully used to create a
nitric oxide, nitrate and nitrite inducible sensor with EcN_pYeaR_GFP. In further
work, this system could be further characterised by testing induction with the various
RNS in combination. This would also further elucidate the interplay between the
NsrR repressor and the Nar two-component system. While it was clearly shown that
EcN_pYeaR_GFP could detect bacterial NOS from NOSBan, it would be enlightening
to fully quantify the concentration of nitric oxide, nitrate and nitrite produced by
this system. Although these systems have been previously reported in the literature,
this piece of work shows full and quantitative characterisation of the systems in EcN.
The regulatory and promoter region of the prpBCDE operon was successfully used to
create a sensor induced by propionate; a vital intestinal SCFA. The impact of catabolic
repression on the EcN_pProE_GFP sensor could be further investigated by growing
the strain with lower concentrations of glycerol or alternative carbon sources such as
glucose. The regulatory and promoter region of the cadBA operon was also successfully
used to create a sensor capable of detecting a decrease in pH. The fact that the system
only functioned in LB and not M9 media means that the mechanisms behind the
regulation of the cadBA operon need to be further investigated.
Collectively, these sensors need to be characterised further to eventually investigate
their capabilities with in vivo experiments or clinical samples.
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4. Caenorhabditis elegans: An Emerging
Model for Studying the Intestinal Micro-
biota
4.1 Introduction
The ability of researchers to ask complex questions and unravel the multifaceted role of
the microbiome in the health of a host is partly due to the development of informative
animal models. In conjunction with the rapid advancement of sequencing and meta-
genomic pipelines, these models have enabled the design and execution of experiments
that have delineated the mechanisms by which the microbiome helps shape the host’s
physiology and propensity to disease.
These animal models are also vital in the development of novel investigative and
therapeutic synthetic biology tools where the eventual aim is to design systems that are
robust enough to function in the complex in vivo gut environment. Characterisation of
tools such as bacterial biosensors (see Chapter 3) in vivo as opposed to just in culture
is critical for their iterative development and eventual use in a clinical setting.
4.1.1 Current Model Systems for Studying the Intestinal Microbiota
Although there can be significant interindividual variation observed within species, a
broad trend exists in the composition of the intestinal microbiota, particularly at the
phylum level [23]. Experimental model based systems including mice, insects and fish
continue to provide valuable and striking insights into how the microbiota interacts
with the host in the gut. The abundance of historic biological tools developed for use
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in these systems provide opportunities to perturb, engineer, and study this interplay
with a level of experimental control that is not possible in humans. Several factors
within the organism’s anatomy and physiology dictate the suitability of the model for
the investigative experiment. For instance, whether the intestines are anaerobic, as is
the case for mice and zebrafish, or aerobic, as is the case for Drosophila [162].
Due to their high reproductive capacity, genetic tractability and vast abundance
of tools, Drosophila has been used to broaden our understanding of cellular and de-
velopmental biology for decades. Recent studies have shown that they have a reduced
microbiota consisting of less than 30 species that are both aerobic and culturable [163].
This provides a potentially valuable symbiont model where the microbial community
can be easily engineered in a highly genetically malleable host. A recent unexpected
finding demonstrated that Drosophila prefer to mate with flies with similar intestinal
microbes [164]. After initial results linking diet to their mating preferences, researchers
discovered that this could be sufficiently manipulated with antibiotics and the intro-
duction of a single symbiont strain.
The zebrafish offers another tractable model but with a more complex physiology
and diverse microbiota [23]. The optical transparency and rapid development of em-
bryos and larvae enable a host with powerful genetic and chemical screens. As a
vertebrate, the zebrafish bears an adaptive immune system; a vital and complex layer
in the interplay between the host and the intestinal microbiota. In light of this, it has
even been used as a model of inflammatory bowel disease [165].
The mouse is by far the most widely used model to study the intestinal microbiome
[166]. As well possessing similar taxonomic levels of the microbiota to humans, the
mammalian physiology offers a closer mimicry of the interaction between the gut and
the host’s diet, genetics and immune system. There is extensive knowledge of their
genetic background with custom genotypes and phenotypes. A particularly powerful
capability of this model is the use of humanised gnotobiotic mice where germ free
mice are inoculated with a human gut microbiota sample. This leads to a mimicry of
the human gut microbiota phylogenic composition and allows researcher to investigate
perturbations in a human-like system [167, 168, 169]. Almost every synthetic biology
approach to engineer or monitor the intestinal microbiota in vivo has been demonstrated
with the mouse model [64, 65, 67, 91, 160, 68]. However, it is this very complexity
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of the mouse intestinal microbiome that provides doubt over the suitability of the
model to some investigative questions. While our understanding of this interplay is
still significantly lacking, the complexity in the model could mask findings and prevent
the ability to ask precise fundamental questions between the host and the intestinal
microbiota. This is particularly important considering that the majority of the cross-
talk between the gut microbiota and the host is host-specific [162]. Furthermore, there
is a considerable problem with non-reproducible findings due to genetic variability,
handling techniques, mouse vendors and diet [170, 171]. Unlike other models, the
anaerobic conditions of the mouse intestines also prevents the use of oxygenase reporters
such as fluorescent or luminescent proteins for live spatiotemporal information in vivo.
The cost, time and specialist skillsets needed to run mammalian models for these
studies struggle to complement the underlying approach of the ‘design, test and build
cycle’ that is fundamental in the field of synthetic biology (see Section 1.2). In light of
this, there is a desire to use models that are compatible with this approach but are still
robust and informative enough to ask elucidative questions. Considerations include
interactions with the immune system, throughput and timescale of experiments and
regulatory hurdles (Figure 4.1).	
 Advantages Disadvantages 
Drosophila Powerful host genetic system; simple culturable microbiota No adaptive immune system 
Zebrafish Powerful host genetic system; adaptive immunity Very simple digestive track 
C.elegans Powerful host genetic system; innate immunity; simple culturable microbiota Very simple digestive track 
Mice Many similarities to the human digestive tract; controlled environment Limited throughput; limited controls, expensive 
Humans Most clinically relevant Limited experiment controls 
Figure 4.1: Table of considerations in choosing a model organism for microbiome stud-
ies. Adapted from [23].
4.1.2 C. elegans as a Model for Host-Microbiota Studies
Caenorhabditis elegans is a transparent nematode worm 1mm in length that lives in
temperate soil environments and feeds on soil bacteria. It was the first multicellular
organism to have its whole genome sequenced in 1998 [172] and the combination of a
short 2-3 week lifespan, transparent cell wall and genetic tractability has enabled it to
become a biological workhorse used to extensively study energy metabolism, immunity
and ageing [173].
While the C. elegans worm demonstrates a diverse microbiota in the wild [174], it
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Figure 4.2: Representative image of C. elegans after feeding on E. coli OP50 expressing
a tomato red fluorescent protein (Adapted from [179]). Red indicates the shape and
length of the intestines. Left is brightfield, centre is fluorescent and right is merged.
Scale bars are 50µm.
is typically monoxenically grown with one species in the lab. This enables researchers
to easily create and maintain a defined intestinal microbiota. The intestines are one
of the major organs and constitutes roughly a third of their somatic mass [175]. The
transparent cell wall and aerobic lumen also enable the simple visualisation of fluor-
escent proteins and markers (Figure 4.2). Even though it is not as advanced as the
adaptive system observed in vertebrates, the worm possesses an innate immune system
which is used to regulate the intestinal bacterial load as it ages [176]. Peak transition of
bacteria through the intestines can be as short as 2 minutes during young adulthood,
although they eventually colonise the lumen in a number of days as the worm ages
[177]. The ability to create a powerful yet simple and defined host-microbiota model
system is leading to a growing number of investigations using C. elegans.
A recent demonstration of the potential power of C. elegans as a microbiome model
was done using high-throughput screens to elucidate the complexity underlying host-
microbe-drug interactions and inter-individual variability [178]. Using C. elegans and
E. coli, researchers showed that bacterial metabolism could boost or suppress the effects
of a common cancer drug through microbial metabolic drug interconversion.
More recently, C. elegans was used as a live in vivo model to demonstrate a synthetic
biology approach to prevent gut infection with an engineered probiotic E. coli Nissle
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1917 (EcN) strain [135]. After designing and characterising a sense-and-kill synthetic
circuit in EcN, the researchers were able to show that the engineered EcN strain could
colonise the worm to prevent a Pseudomonas aeruginosa gut infection. Furthermore,
the use of C. elegans and fluorescent proteins in EcN enabled them to visualise this
approach in a spatiotemporal manner in vivo. This work demonstrates that it is in-
deed possible to formulate and test synthetic biological approaches to engineering the
intestinal microbiome with the use of C. elegans.
Recent work with C. elegans and their bacterial diets further uncovered the role of
certain metabolites in worm gene expression and lifespan [180]. Using system biology
approaches, it was shown that the bacterial derived vitamin B12 not only affects worm
development but also prevents a toxic build up of propionate in the intestines.
The discussed characteristics of C. elegans could pave the way for further investig-
ations into host-microbiome interactions in the intestines with synthetic biology. EcN
bacterial sensors could also be be characterised in vivo using C. elegans as a model
system.
4.2 Aims
The emerging need for both convenient and robust tools to investigate the relationship
between the host and microbiome has resulted in a growing interest in the use of C.
elegans as a live animal model. This piece of work aimed to investigate whether C.
elegans can indeed be used as a live animal model for characterising an inducible EcN
bacterial biosensor in vivo. These aims included:
1. Developing an inducible bacterial sensor system that can be detected quantitat-
ively in vivo.
2. To establish whether C. elegans can develop and grow solely on EcN.
3. The development of an induction assay whereby the signal of an EcN biosensor
can be detected and quantified from the C. elegans intestines in vivo.
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4.3 Materials and Methods
4.3.1 Media and Strains
Lysogeny broth (LB) media and agar was used during propagation and cloning of
bacteria. Assays were carried out in LB or M9 minimal media supplemented with
1mM thiamine hydrochloride, 0.4% glycerol, 0.2% casamino acids, 2mM MgSO4 and
0.1mM CaCl2. When antibiotic selection was applied, kanamycin was used at 25µg/mL
and streptomycin was used at 50µg/mL.
All DNA manipulations were performed in E. coli DH5α (NEB). All sequences were
confirmed via Sanger sequencing (Source Bioscience, UK). All final induction assays
were performed in E. coli Nissle 1917 (EcN) (Prof. Ian Henderson from the University
of Birmingham, UK). Chemically competent EcN was made using standard protocols.
Briefly, this involved diluting an overnight EcN LB culture 1:100 into 50ml of fresh
LB media and grown at 37◦C in a shaking incubator to an OD600 of 0.25 to 0.3. The
culture was then chilled on ice for 15 minutes and then centrifuged for 10 minutes at
5000g and 4◦C. The medium was then discarded and the cell pellet resuspended in 30ml
of cold 0.1M CaCl2 before being kept on ice for a further 30 minutes. This suspension
was then centrifuged for 10 minutes at 5000g and 4◦C. The supernatant was once again
removed and the cell pellet was resuspended in 3ml of cold 0.1M CaCl2 solution with
15% glycerol. The final cell suspension was then aliquoted and flash frozen before being
stored at -80◦C.
4.3.2 Plasmids and Cloning Methods
Ratiometric sensor assay systems were designed with a constitutive mCherry reporter
plasmid and a separate GFP reporter plasmid. The GFP reporter plasmids consisted
of the OG241_GFP constructs previously described in Section 3.4. This included the
promoterless OG241_GFP plasmid (Figure 3.4) which consisted of an upstream mul-
tiple cloning site, a dasher GFP reporter gene, a pUC high copy origin-of-replication
and a kanamycin resistance cassette (Oxford Genetics, UK). As a positive control,
the strong constitutive OXB19 promoter (Oxford Genetics, UK) was placed upstream
of GFP to derive OXB19_GFP. In addition to these constructs, an isopropyl β-D-1-
thiogalactopyranoside (IPTG) inducible GFP sensor (pLac_GFP) was created. Briefly,
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Figure 4.3: Graphical representation of constitutive mCherry plasmid and promoterless
OG241_GFP control plasmid.
Strain Name Host Bacterium Plasmids Plasmid Source 
EcN_OG241_GFP_mCherry E.coli Nissle 1917 OG241_GFP_pUC_Kan
R  (promoterless control) 
p47_M7_mCherry_SC101_StrpR Oxford Genetics, UK 
EcN_OXB19_GFP_mCherry E.coli Nissle 1917 OXB19_GFP_pUC_Kan
R (constitutive control) 
p47_M7_mCherry_SC101_StrpR This work 
EcN_pLac_GFP_mCherry E.coli Nissle 1917 pLac_GFP_pUC_Kan
R (inducible control) 
p47_M7_mCherry_SC101_StrpR  This work 	
Figure 4.4: Table of strains used.
this was created by PCR cloning the region containing the lacI protein, tetR promoter
and trc promoter from pKDL071 [181] and adding SpeI and EcoRI flanks. This re-
gion was then cloned into the MCS of OG241_GFP with the appropriate restriction
enzymes. The p47_mCherry construct was created from pSEVA471, a 3120bp plas-
mid based on the pSEVA format [182]. This involved using pacI and SpeI to clone
out the constitutively expressed mCherry fragment from pTn7-M-pEM7-mCherry and
ligate into the empty MCS of pSEVA471 to derive a low copy SC101 plasmid with
streptomycin resistance and strong constitutive mCherry expression under the pEM7
promoter (Figure 4.3). EcN was then simultaneously transformed with p47_mCherry
and the respective GFP plasmid via heat-shock methods to give the strains listed in
Figure 4.4.
4.3.3 Induction Assays in Liquid Culture
All induction assays were performed over 16 hours at 37◦C and 350RPM at a volume
of 750µL in sterile autoclaved 96-well deep square well (2.2mL) polypropylene plates
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(BRAND R©, Sigma-Aldrich, UK) sealed with Breathe-Easy sealing membranes (Sigma-
Aldrich, UK). Induction was calculated through flow cytometry analysis. IPTG was
used to induce pLac_GFP. Concentration range induction assays were performed by
diluting triplicate overnight cultures 1:500 into LB or supplemented M9 media with the
appropriate inducer concentration. For induction assays in growing phase, overnight
cultures were grown in triplicates and diluted 1:500 into media with the appropriate
inducer. For induction assays in stationary phase, overnight cultures were grown in
triplicates and spun down at 4000g before removing the supernatant and resuspending
in fresh media with the appropriate inducer.
4.3.4 Growth Rate Assays
Overnight cultures were grown in triplicates and diluted 1:500 into LB media with the
appropriate inducer. A sterile autoclaved 96-well deep square well (2.2mL) polypropyl-
ene plate (BRAND R©, Sigma-Aldrich, UK) was then filled with 16 replicates of 750µL
of each culture. The plate was then sealed with a Breathe-Easy sealing membrane
(Sigma-Aldrich, UK) and grown at 37◦C and 350RPM for 16 hours. While maintain-
ing the membrane seal for the rest of the plate, 750µL from each strain-culture was
taken hourly and the OD700 was recorded on a WPA CO8000 Cell Density Meter (Bio-
chrom). OD700 was measured instead of OD600 to minimise the impact of mCherry
fluorescence on the readings [183].
4.3.5 Flow Cytometry Analysis and Plotting
Flow cytometry was performed on an Attune NxT Acoustic Focusing Cytometer with
Attune NxT Autosampler (Thermo Fisher Scientific, UK). 1µL of the appropriate strain
culture was transferred into 200µL of PBS in a shallow polystyrene 96-well plate. The
Attune NxT Autosampler was used to record 10,000 events for each sample with 4
washes between each one. GFP was excited using the blue laser (488nm) and was
detected using a 530/30nm bandpass filter. mCherry was excited with the yellow laser
(561nm) and was detected using a 620/15 bandpass filter. In order to prevent operator
bias associated with manual drawing of gates and speed up the analysis of samples,
a computational pipeline called autoGate was developed by Alexander Fedorec in the
Barnes Lab (github.com/ucl-cssb/autoGate) to automate the gating of singlet bacteria
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Figure 4.5: autoGate clustering and trimming of flow cytometry data.
while excluding background debris and bacterial doublets. Briefly, the method fits
mixture models of one, two and three clusters to the forward-scatter versus side-scatter
data. Using integrated completed likelihood (ICL) [126], the number of clusters that
best fits the data is calculated and the cluster centred closest to the expected bacterial
population coordinate is taken. A linear model is then fitted to the side-scatter-height
versus side-scatter-area data and points falling too far away are removed as doublets.
The levels of trimming are shown in Figure 4.5.
All plots were made using the flowCore and ggplot2 R packages. Non-linear least
squares (nls function in R) curve fitting was used to fit a line to induction plots. This
model approximates the non-linear function using a linear one and iteratively refines the
parameter values to the best fit. Locally weighted least sqaure regression smoothing
(loess function in R) was used to fit lines on EcN growth curve plots. This uses a
local regression model fit to the points to create a smooth line. Relative fluorescent
units (RFU) were shown as mean averages along with the standard error of the mean.
R was also used for all statistics. GFP sensor induction was calculated as a ratio of
median GFP fluorescence to median mCherry fluorescence (GFP:mCherry). The ratio
of GFP:mCherry was calculated by dividing the median GFP fluorescence (x) by the
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median mCherry fluorescence (y) (Equation 4.1). The standard error of the ratio (σR)
was calculated with Equation 4.2 where sx is the standard error x and sy is the standard
error of y.
R = x
y
(4.1)
σ2R = R2((
sx
x
)2 + (sy
y
)2) (4.2)
4.3.6 C. elegans Strains and Handling
All C. elegans experiments were carried out in the wild-type lab strain N2 Bristol
(provided by the Caenorhabditis Genetics Center, USA). Unless stated otherwise,
worms were maintained and raised at 20◦C on nematode growth medium (NGM) seeded
with E. coli OP50, an auxotroph lab strain whose growth is limited on NGM.
Adult worms were maintained and passaged according to normal protocols. Briefly,
this involved seeding NGM agar plates with 150µL of overnight E. coli OP50 culture
and incubating for 48 hours at 20◦C to create a bacterial lawn for food. Five to six
L4-stage worms were picked and transferred to seeded NGM plates and incubated for
24 hours so that they become adults and start laying eggs. After 24 hours, the adult
worms are removed from each plate and killed. The plates are incubated for a further
48 hours to enable the large number of eggs to hatch, feed on the bacterial lawn and
become heavily pregnant with eggs.
After 48 hours, an egg prep was carried out to isolate the eggs from the pregnant
worms. This involved washing NGM plates with M9 media to collect all worms and
transferring to a falcon tube. Once settled, the M9 media was aspirated and the
remaining worms were washed with 2mls of bleach and NaOH at a ratio of 7:8. The
mixture was then vortexed for 3-4 minutes and then neutralised with 13mls of M9.
The tube was then centrifuged for 3 minutes at 4000RPM and once again the M9
media was aspirated without disturbing the pellet. This wash was repeated twice more
before the egg pellet was resuspended with 10mls of M9 media and transferred into
an empty dish for 24 hours incubation. This incubation allows the eggs to hatch but
since there is no food the larvae does not develop past the first larval stage (L1) and
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provides an entirely synchronised population. After 24 hours incubation, 400 L1s were
seeded on the appropriate bacterial NGM plate for experiments or re-passaging. Where
described, worms were passaged as sterile and non-reproductive adults with the drug
fluorodeoxyuridine (FUdR). This involved picking L4 worms and transferring them to
seeded NGM plates coated with FUdR at a concentration of 20µM for at least 24 hours.
This enables the maintenance of a synchronously ageing population of worms.
Individual EcN-NGM plates were prepared in the same manner as with E. coli OP50
but with an overnight antibiotic culture of the respective EcN sensor strain or control
instead. After preparing the worms as previously described, synchronised 400 L1 stage
worms were transferred to NGM plates seeded with the respective EcN strain. These
included EcN_OXB19_GFP_mCherry and EcN_OG241_GFP_mCherry as positive
and negative controls, respectively. The inducible EcN_pLac_GFP_mCherry was
used to investigate the sensor assay. After 48 hours of growth on the respective EcN-
NGM plates, 45-50 L4 worms were picked and transferred to FUdR coated NGM plates
seeded with the same EcN strain as before. Adult worms were picked and transferred
to fresh FUdR coated EcN-NGM plates every 3-4 days.
4.3.7 EcN Biosensor Induction Assays in C. elegans
Figure 4.6 gives a graphical representation of the induction assay. As the worms
age, the peristaltic movements in their intestines decrease and they eventually become
constipated while the bacteria proliferates in the gut [173]. Induction assays were
carried out on 7 day old adult worms after being grown on NGM plates with EcN.
25 to 30 worms were picked from the respective EcN-NGM plates and transferred to
either an unseeded plain NGM agar plate (without bacteria) or an unseeded NGM agar
plate (without bacteria) containing 1mM of IPTG. Plates were then stored at 20◦C for
the duration of the assay. After 8 hours induction, worms were picked from either the
control NGM plate or the the assay plate and transferred to a separate plain NGM
agar plate before being anaesthetised for imaging with 0.2% levamisole.
4.3.8 C. elegans Imaging and Biosensor Quantification
Anaesthetised worms were imaged with a Zeiss Axio Scope using GFP (excitation:
470nm; emission: 525nm) and mCherry (excitation: 560nm; emission: 630nm) filters.
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Exposure times were set at 500ms for each and laser intensities were kept constant.
Images were acquired using the Zen software and analysed using FIJI. For both GFP
and mCherry images, the background was subtracted with a rolling ball radius of a
1000 pixels. The mCherry channel was then used to manually draw a region of interest
(ROI) identifying the worm intestines. Using the same ROI, the mean pixel density
was measured for both mCherry and GFP channels. The two values were then used to
derive the GFP:mCherry ratio for each worm imaged. Where appropriate, the Mann-
Whitney U test used to demonstrate statistical significance. All plots were done with
the ggplot2 package in R.
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Figure 4.6: Graphical representation of induction assay protocol with EcN-NGM plates
and sensor induction quantification using GFP:mCherry ratio.
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4.4 Results
In order to quantitatively and accurately detect biosensor circuit signals in an in vivo
environment, a dual-plasmid system was designed and created in EcN (Figure 4.7).
This approach would enable the detection of the sensor circuit GFP signal irrespective
of the surrounding environment. Here a constitutively expressing mCherry plasmid was
designed and transformed into EcN in conjunction with the previously characterised
sensors in Section 3.5. The GFP induction of the sensor circuit could be quantified by
detecting the ratio of GFP signal to the constant mCherry signal.
Initial attempts to incorporate an mCherry fragment onto the same existing GFP
sensor plasmids were unsuccessful in EcN. While initial cloning attempts were success-
ful, protein expression and plasmid propagation were faulty. This was most likely due
to the high burden of the plasmid leading to recombination. Using the dual plasmid
approach instead, a variety of ratiometric constructs were designed and created in EcN
using the p47_mCherry and OG241 plasmids (Figure 4.7).
EcN_OG241_GFP_mCherry was created as a negative control with the promoter-
less OG241_GFP plasmid. The EcN_OXB19_GFP_mCherry was created as a posit-
ive control with the constitutive OXB19_GFP plasmid. The IPTG inducible EcN_pLac
_GFP_mCherry sensor strain with the pLac_GFP plasmid. All constructs were sub-
sequently characterised in EcN.
Figure 4.7: A) Plasmid maps of GFP based reporter sensors consisting of a promoter-
less OG241_daGFP plasmid, constitutive OXB19_GFP reporter and IPTG inducible
pLac_GFP reporter. B) Constitutive p47_mCherry reporter.
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4.4.1 GFP:mCherry Ratio Quantifies Sensor Induction in vitro
Figures 4.8 to 4.11 show that while mCherry expression was identical in both the
negative promoterless and positive constitutive control strains, the maturation of the
red protein took far longer than the maturation of GFP. This delay in median mCherry
fluorescence over the time-assay indicates that while the production of mCherry may
be constitutively and constantly driven by the promoter during cell growth, there will
be delay in detection until the protein matures. In comparison, the fast maturation of
GFP only results in a slight delay in detection during growth (Figure 4.11).
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Figure 4.8: EcN_OG241_GFP_mCherry (negative promoterless GFP control) GFP
induction over 15 hours in LB. Top, histogram density plot of GFP fluorescence over
15 hours growth. Bottom, median GFP fluorescence over 15 hours growth. Flow
cytometry data with 10,000 events (n=3).
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Figure 4.9: EcN_OG241_GFP_mCherry (negative promoterless GFP control) mCh-
erry induction over 15 hours in LB. Top, histogram density plot of mCherry fluorescence
after 15 hours growth. Bottom, median mCherry fluorescence after 15 hours growth.
Flow cytometry data with 10,000 events (n=3).
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Figure 4.10: EcN_OXB19_GFP_mCherry (positive constitutive GFP control) GFP
induction over 15 hours in LB. Top, histogram density plot of GFP fluorescence after
15 hours growth. Bottom, median GFP fluorescence after 15 hours growth. Flow
cytometry data with 10,000 events (n=3).
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Figure 4.11: EcN_OXB19_GFP_mCherry (positive constitutive GFP control) mCh-
erry induction over 15 hours in LB. Top, histogram density plot of mCherry fluorescence
after 15 hours growth. Bottom, median mCherry fluorescence after 15 hours growth.
Flow cytometry data with 10,000 events (n=3).
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Even with the differences in maturation times, a distinctively higher GFP:mCherry
ratio can be detected between the negative EcN_OG241_GFP_mCherry and the pos-
itive EcN_OXB19_GFP_mCherry control (0.0125±0.0001 compared to 0.471±0.004
at 15 hours of growth) (Figure 4.12). Due to the lag of maturation, the ratio of
GFP:mCherry is particularly high during the logarithmic stages of growth (0 to 8
hours)(Figures 4.13 and 4.14). In line with this, the difference in ratio between the
strains is also apparent at the stationary phase of growth when the OD700 is larger
than 1.5 (Appendix Figure 5.9).
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Figure 4.12: GFP to mCherry ratio in EcN_OG241_GFP_mCherry and
EcN_OXB19_GFP_mCherry during growth in LB media from 8 to 15 hours. Ra-
tio calculated using median fluorescence for each reporter from flow cytometry data
with 10,000 events (n=3).
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Figure 4.13: GFP to mCherry ratio in EcN_OG241_GFP_mCherry during growth in
LB media for 15 hours. Ratio calculated using median fluorescence for each reporter
from flow cytometry data with 10,000 events (n=3).
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Figure 4.14: GFP to mCherry ratio in EcN_OXB19_GFP_mCherry during growth in
LB media for 15 hours. Ratio calculated using median fluorescence for each reporter
from flow cytometry data with 10,000 events (n=3).
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Figures 4.15 and 4.16 show that increasing concentrations of IPTG can be used to
achieve a maximum 25 fold increase in GFP fluorescence in EcN_pLac_GFP_mCherry
with minimal impact on mCherry expression. Similar results were observed in induction
with supplemented M9 media instead of LB (Figures 4.17 and 4.18). In a similar
manner to the negative promoterless and positive constitutive controls, the uninduced
EcN_pLac_GFP_mCherry strain demonstrated a lagged but steady level of mCherry
expression over 15 hours (Figures 4.19 and 4.20).
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Figure 4.15: EcN_pLac_GFP_mCherry induction with IPTG in LB media. Top:
histogram density plot of GFP fluorescence after 16 hours induction. Bottom: median
GFP fluorescence after 16 hours induction. Flow cytometry data with 10,000 events
(n=3).
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Figure 4.16: EcN_pLac_GFP_mCherry induction with IPTG in LB media. Top:
histogram density plot of mCherry fluorescence after 16 hours induction. Bottom:
median mCherry fluorescence after 16 hours induction. Flow cytometry data with
10,000 events (n=3).
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Figure 4.17: EcN_pLac_GFP_mCherry induction with IPTG in M9 media. Top:
histogram density plot of GFP fluorescence after 16 hours induction. Bottom: median
GFP fluorescence after 16 hours induction. Flow cytometry data with 10,000 events
(n=3).
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Figure 4.18: EcN_pLac_GFP_mCherry induction with IPTG in M9 media. Top:
histogram density plot of mCherry fluorescence after 16 hours induction. Bottom:
median mCherry fluorescence after 16 hours induction. Flow cytometry data with
10,000 events (n=3).
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Figure 4.19: GFP expression in uninduced EcN_pLac_GFP_mCherry during 15 hours
of growth in LB media. Top: histogram density plot of GFP fluorescence over 15 hours.
Bottom: median GFP fluorescence over 15 hours. Flow cytometry data with 10,000
events (n=3).
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Figure 4.20: mCherry expression in uninduced EcN_pLac_GFP_mCherry during 15
hours of growth in LB media. Top: histogram density plot of mCherry fluorescence
over 15 hours. Bottom: median mCherry fluorescence over 15 hours. Flow cytometry
data with 10,000 events (n=3).
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Figure 4.21 shows that the ratio of GFP:mCherry markedly increases from 0.037±0.0002
whilst uninduced to 0.82±0.0008 after overnight induction in 750µM of IPTG. Higher
fold increases in this ratio were also observed in induction assays carried out in sup-
plemented M9 media (from 0.032±0.0002 to 1.43±0.16) (Figure 4.22). This was most
likely due to lower levels of basal expression whilst uninduced.
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Figure 4.21: GFP to mCherry ratio in EcN_pLac_GFP_mCherry after induction
with IPTG in LB media overnight. Ratio calculated using median fluorescence for each
reporter from flow cytometry data with 10,000 events (n=3).
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Figure 4.22: GFP to mCherry ratio in EcN_pLac_GFP_mCherry after induction
with IPTG in M9 media overnight. Ratio calculated using median fluorescence for
each reporter from flow cytometry data with 10,000 events (n=3).
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Figure 4.23 demonstrates that once induced at 1mM IPTG after 7 hours of growth,
the induction of the pLac_GFP plasmid results in a significant increase in the GFP
to mCherry ratio in EcN_pLac_GFP_mCherry in comparison to the uninduced con-
trol. After 15 hours of growth, the GFP:mCherry ratio was 0.21±0.0006 in the induced
strains in comparison to the uninduced ratio of 0.026±0.001. Figure 4.24 shows the in-
crease of GFP expression rapidly upon induction while mCherry returns to its constant
expression levels. Due to the lag of mCherry maturation, the ratio of GFP:mCherry is
particularly high during the logarithmic stages of growth (0 to 8 hours)(Figures 4.25
and 4.26). The difference in ratio between the uninduced and induced strains is also ap-
parent at the stationary phase of growth when the OD700 is larger than 1.5 (Appendix
Figure 5.10). The discrepancy observed between the ratio here at 1mM (0.21±0.0006)
and the ratio after overnight growth in 1mM (0.76±0.0005) (Figure 4.21) is most likely
due the strain not being induced at the logarithmic phase of growth.
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Figure 4.23: GFP to mCherry ratio in EcN_pLac_GFP_mCherry after induction
with 1mM IPTG at 7 hours of growth in LB media. Ratio calculated using median
fluorescence for each reporter from flow cytometry data with 10,000 events (n=3).
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Figure 4.24: GFP and mCherry expression in EcN_pLac_GFP_mCherry after induc-
tion with 1mM IPTG at 7 hours of growth in LB media. Top: median GFP fluorescence
over 15 hours. Bottom: median mCherry fluorescence over 15 hours. Flow cytometry
data with 10,000 events (n=3).
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Figure 4.25: GFP to mCherry ratio in EcN_pLac_GFP_mCherry during growth un-
induced in LB media. Ratio calculated using median fluorescence for each reporter
from flow cytometry data with 10,000 events (n=3).
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Figure 4.26: GFP to mCherry ratio in EcN_pLac_GFP_mCherry during growth in-
duced at 1mM IPTG at 7 hours in LB media. Ratio calculated using median fluores-
cence for each reporter from flow cytometry data with 10,000 events (n=3).
126
4.4.2 EcN Sensors can Detect and Report on Signals in C. elegans in
vivo
While both EcN and C. elegans are widely used as model organisms in a plethora of
investigative fields, there is only one published example of their combined use [135].
In that example, it was shown that C. elegans can be used as a live in vivo model to
demonstrate a synthetic biology approach to prevent gut infection with an engineered
probiotic E. coli Nissle 1917 (EcN) strain. It has not been investigated whether bac-
terial biosensors can be characterised in C. elegans. Initial preliminary experiments
here showed that the wild type lab BW C. elegans strain could indeed grow and de-
velop successfully with a EcN_OXB19_GFP control strain constitutively expressing
GFP. In addition, the GFP signal could be successfully used to image the C. elegans
intestine (Figure 4.27).
Figure 4.27: Representative image of 7 day old C. elegans worm grown on
EcN_OXB19_GFP constitutively expressing GFP. GFP shows localisation of the
strain from the pharynx onwards and throughout the intestines. Top, imaged at 120x
magnification. Bottom, imaged at 200x magnification.
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Figures 4.28 and 4.29 demonstrate the positive and negative EcN_GFP_mCherry
strains functioning as expected in vivo. EcN_OXB19_GFP_mCherry shows direct
co-localisation with strong expression of both GFP and mCherry throughout (Figure
4.28). The negative GFP control EcN_OG241_GFP_mCherry shows only high levels
of mCherry throughout (Figure 4.29).
Figure 4.28: Representative image of 5 day old C. elegans worm grown on
EcN_OXB19_GFP_mCherry constitutively expressing GFP and mCherry as a posit-
ive control. Both channels show localisation of the strain from the pharynx onwards
and throughout the intestines. All images at 160x magnification. Scale bars are 50µm.
BF indicates brightfield image.
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Figure 4.29: Representative image of 5 day old C. elegans worm grown on
EcN_OG241_GFP_mCherry constitutively expressing mCherry. The promoterless
OG241 plasmid acts as a negative sensor control. mCherry shows localisation of the
strain from the pharynx onwards and throughout the intestines. All images at 160x
magnification. Scale bars are 50µm. BF indicates brightfield image.
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As expected, the IPTG inducible EcN_pLac_GFP_mCherry strain showed negli-
gible levels of GFP fluorescent in the C. elegans intestines when plated and grown on
plain NGM agar plates after an egg-prep (Figure 4.30). However, when the worms
and EcN_pLac_GFP_mCherry strain were plated on NGM agar plates supplemented
with 1mM IPTG, strong levels of GFP expression were observed co-localised with the
mCherry signal in the intestines (Figure 4.31). This indicates that the pLac sensor
plasmid could report on the IPTG in the surrounding environment from the C. elegans
intestines.
Figure 4.30: Representative image of 5 day old C. elegans worm grown on uninduced
EcN_pLac_GFP_mCherry constitutively expressing mCherry. The pLac plasmid is
IPTG inducible. mCherry shows localisation of the strain from the pharynx onwards
and throughout the intestines. All images at 160x magnification. Scale bars are 50µm.
BF indicates brightfield image.
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Figure 4.31: Representative image of 5 day old C. elegans worm grown on the
EcN_pLac_GFP_mCherry strain plated on NGM agar plates with 1mM IPTG. The
GFP expression indicates the pLac sensor plasmid detecting the IPTG in the environ-
ment. All images at 160x magnification. Scale bars are 50µm. BF indicates brightfield
image.
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Figure 4.32 shows that the differences between the strains can be sufficiently quan-
tified using the ratio of GFP:mCherry. Furthermore, the induction of GFP in the pLac
plasmid could be clearly observed on worms colonised by EcN_pLac_GFP_mCherry
and plated on NGM agar with IPTG for 7 days.
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Figure 4.32: Box plot of GFP:mCherry ratio in individual 7 day old C. elegans worms
grown on EcN sensor strains and plated on NGM agar plates. Worms colonised with
EcN_pLac_GFP_mCherry were additionally plated on NGM agar plates with 1mM
IPTG to demonstrate sensor induction over 7 days. 25 to 30 worms imaged for each
condition.
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In order to demonstrate that the EcN_pLac_GFP_mCherry strain could detect
and report on an environmental signal from within the C. elegans intestines in a dy-
namic manner, an induction assay was carried out where worms grown on the sensor
strain with NGM agar plates were transferred 7 days later to NGM agar plates supple-
mented with 1mM IPTG (see Section 4.3). Worms were then imaged after 8 hours to
detect GFP and mCherry levels as a way of quantifying the sensor induction over time.
Figure 4.33 shows that there was no significant increase in the ratio on the worms
transferred from a plain NGM agar plate to another plain plate. However, significant
differences were observed in the ratios when the worms were transferred to a NGM
agar plate supplemented with 1mM IPTG. Within 8 hours, the median GFP:mCherry
ratio was significantly higher on those on the IPTG plates in comparison to the plain
NGM plates (0.39 compared to 0.21, p < 0.0001). No differences were observed in the
negative OG241 and positive OXB19 controls (Appendix Figure 5.11).
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Figure 4.33: Box plot of GFP:mCherry ratio in individual 7 day old C. elegans worms
grown on EcN_pLac_GFP_mCherry sensor strains and transferred to either plain
NGM agar plates or plates supplemented with 1mM IPTG for 8 hours. 27 to 30 worms
imaged for each condition and triple asterisk indicates p < 0.0001.
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4.5 Discussion
Detecting markers of interest through inducible reporter systems can enable the design
of more complex therapeutic circuits. The ability of EcN to occupy various niches in
the intestines means it is particularly relevant to the detection of dysbiotic markers
in the gut. In line with this, a dual reporter system with both mCherry and GFP
was created in EcN. While GFP is inducible in the circuit, mCherry is constitutively
expressed and could be used to calculate a ratiometric fold increase in GFP induction
as opposed to absolute induction. This approach is considered to be more effective in
reducing background noise and fluctuation of diverse conditions in vivo [184, 185].
The dual mCherry and GFP system was initially characterised with EcN in liquid
LB culture. In comparison to the positive constitutive OXB19_GFP_mCherry and
negative promoterless OG241_GFP_mCherry controls where the GFP:mCherry re-
mained constant (Figure 4.12), the pLac inducible system showed a robust increase in
the ratio upon induction (Figures 4.21 to 4.22).
The pLac_GFP_mCherry system was capable of showing an increase in the ratio
from 0.037±0.0002 whilst uninduced to 0.82±0.0008 after overnight induction in 750µM
of IPTG (Figure 4.21) in LB. Timecourse experiments indicated that this increase could
be detected rapidly within 2 hours of induction (Figure 4.23).
While the half-time for mCherry was initially published at being similar to that
of GFP at 15 minutes [186], several reports indicate that the maturation can in fact
range from 40 to 100 minutes in E. coli [187, 188]. This difference corresponds to data
presented here where there was a substantial lag in mCherry detection in comparison
to GFP in flow cytometry experiments (Figures 4.10 and 4.11). Even so, the use
of the GFP:mCherry was viable after 7 or 8 hours when the EcN strains were out of
logarithmic growth.
In line with the sole piece of published research on the combined use of EcN and C.
elegans [135], preliminary experiments showed that the wild type lab BW C. elegans
strain could indeed grow and develop successfully with an EcN strain expressing GFP.
In addition, the GFP signal could be successfully used to clearly image the intestines
(Figure 4.27).
Figures 4.28 to 4.31 show that it is possible to clearly visualise the dual plasmid
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GFP and mCherry EcN strains in C. elegans. Furthermore, Figure 4.31 shows that a
substantial increase in GFP expression can be observed from EcN_pLac_GFP_mCherry
throughout the intestines when the worms were plated on NGM plates supplemented
with 1mM of the IPTG inducer. In addition, Figure 4.32 shows that the increase
in GFP:mCherry from this strain can be clearly recorded and quantified from live C.
elegans in vivo. This demonstrates that the bacteria can detect and respond to envir-
onmental signals from within the worm intestines during colonisation.
To further confirm this finding in a dynamic and spatiotemporal manner, a time-
course induction assay was performed where worms with EcN_pLac_GFP_mCherry
that were grown on plain seeded NGM plates throughout were transferred to unseeded
NGM agar plates with no bacteria but supplemented with 1mM IPTG. Due to there
being no bacteria on these induction plates, it would also be possible to confirm that it
was in fact the intestinal bacteria detecting and responding to the environmental signal.
Figure 4.33 shows that a significant increase in GFP:mCherry ratio from 0.21 to 0.39
(p < 0.0001) can be detected from within the intestines after only 8 hours of placing
the worms on an IPTG plate. While this was a near 100% increase in the ratio, it can
be argued that a higher fold increase like the one in Figure 4.31 (0.24 to 0.76) could
have been recorded if the worms were incubated for longer than 8 hours. However, it
is not known what impact the lack of bacterial food would have on the worms for such
a long time. In line with the liquid culture experiments, it would also be inquisitive to
investigate the limits of this detection system in vivo by using a diverse range of IPTG
concentrations on the NGM induction plates.
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4.6 Conclusions and Further Work
As set out in the aims, this piece of work demonstrated that it was possible to use
C. elegans as a live animal model for characterising EcN sensors in vivo. Initially, it
was shown that EcN sensors could be further developed to work in liquid culture in a
ratiometric manner using a constitutive mCherry signal and inducible GFP signal. The
incorporation of this approach allow EcN sensors to function with less background noise
and in a more independent manner from the surrounding environmental conditions both
in culture and in vivo. It was shown that C. elegans can survive and grow on these
dual reporter EcN strains and that the fluorescent signal could be easily detected from
the intestines of the live model. After colonisation, the dual signals were quantified in a
ratiometric manner in vivo. Finally, it was shown that the EcN_pLac_GFP_mCherry
strain could detect and respond to environmental signals directly from within the in-
testines of the live C. elegans model.
Further work would build on the propionate inducible EcN_pProE_GFP and pH
sensitive EcN_pCadC_GFP sensors described in Section 3. The sensors could be
altered into a dual system with the mCherry plasmid and investigated in vivo in C.
elegans. Building on previous work on host-derived metabolites in C. elegans [180], the
pProE sensor could be used to demonstrate the precise detection of a worm derived
compound directly from within the intestines. Furthermore, the pCadC system could
be used to elucidate the changing pH gradient of the worm intestines throughout de-
velopment. Initial attempts were made to create a dual GFP:mCherry reporter system
on a single plasmid. In light of these constructs being unstable in EcN, a dual plasmid
approach was used. Further work could include reattempting the single-plasmid ap-
proach as it should in theory enable more accurate ratiometric analysis than a system
with fluorescent reporters on two separate plasmids that have two independent origins
of replication. As these origins of replication maintain plasmid copy number independ-
ently in the host, it can add an additional variable to the ratio of the two fluorescent
reporters during sensor induction and readout.
Collectively, these findings indicate that the live C. elegans model can be used to
design precise intestinal investigations. With minimal regulatory and time constraints,
experiments can be carried out on a powerful yet simple and defined host-microbiota
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model system. Furthermore, this model has the potential to complement the underlying
approach of the ‘design, test and build cycle’ that is crucial to synthetic biology.
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5. Conclusions
This body of work set out to investigate the use of synthetic biology tools for unraveling
the underlying mechanisms of the complex and multifaceted intestinal microbiota. In
addition to building on the latest research in these dynamic fields, the attempts made
here tried to broaden the established methodologies and approaches currently in use.
The commensal attributes and research already carried out on E.coli Nissle 1917 (EcN)
made it an ideal chassis to base these approaches on. Novel insights and findings like
these could eventually be utilised to help further elucidate the underlying role of the
microbiota in conditions such as inflammatory bowel disease (IBD) and cancers of the
gasterointestinal tract.
Initially, it was shown here that it is possible to use PSK systems such as Hok/sok,
Axe/Txe and microcin V to stabilise synthetic gene networks in the probiotic EcN
strain in the absence of antibiotic selection for up to 37 passages in liquid culture. In
addition, it was demonstrated that the Axe/Txe and Hok/sok systems could substan-
tially stabilise a luminescent reporter plasmid in an in vivo tumour xenograft model
without antibiotic selection. Whereas the stability provided by the Hok/sok system
corroborates with previous literature, the novel findings here show that Axe/Txe was a
superior plasmid stability system in EcN. The E.faecium derived Axe/Txe system was
particularly effective in preventing a reporter plasmid dropping from the population.
These novel findings can be used to design and execute more robust in vivo investiga-
tions into the intestinal microbiota without the use of antibiotics. Experiments could
be repeated in other commensal strains such as Salmonella typhimurium or with dif-
ferent in vivo animal models. While a tumour xenograft model was investigated here,
it would be enlightening to see how effective the Axe/Txe system is in stabilising a
genetic construct within a healthy or diseased intestine.
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Next it was demonstrated that is possible to design and characterise a range of
therapeutic sensors in EcN that could detect RNS, propionate and changes in pH.
As RNS are a common marker within intestinal inflammation, the RNS inducible pY-
eaR_EcN sensor could be used to investigate the underlying mechanisms of IBD in vivo
or from clinical samples. The propionate inducible pProE_EcN sensor could be used
during in vivo investigations to broaden our understanding of the role SCFAs play in
intestinal pathologies. The pH sensitive pCadC_EcN sensor could be eventually used
to investigate the changing pH in the intestines of an organism, or be used to create a
circuit switch that only initiates protein expression at a given pH range.
Finally, work presented here demonstrated that it was possible to use C.elegans as a
live animal model for quantitatively characterising EcN biosensors in vivo. While this
live animal model is used extensively throughout biological experiments, it has only
been recently proposed as a useful model for investigating host-microbe interactions
in the intestines. It was shown that C.elegans can survive and grow on EcN strains
with dual reporters and that the fluorescent signals could be easily detected from the
intestines of the live model. After colonisation, the dual signals could be detected in a
ratiometric manner in vivo. Using this approach, it was shown that an IPTG inducible
EcN strain could detect and respond to environmental signals directly from within the
intestines of the live C.elegans model in a time dependent manner. Further work would
consist of employing this approach to the propionate inducible EcN_pProE_GFP and
pH sensitive EcN_pCadC_GFP sensors described in Chapter 3. Experiments could
be devised that show these sensors dynamically responding to host-derived metabolites
in vivo directly from the intestines. Collectively, these novel findings indicate that the
live C.elegans model can be used to design precise intestinal microbiome investigations.
With minimal regulatory and time constraints, experiments can be carried out on
a powerful yet simple and defined host-microbiota model system. Furthermore, this
model has the potential to complement the underlying approach of the ‘design, test
and build cycle’ that is fundamental in the field of synthetic biology.
Taken together, these findings indicate that it is possible to build on existing lit-
erature to expand the foundational components and genetic repertoire of synthetic
biology tools for robust investigations into the intestinal microbiota. By incorporating
approaches like these, we will be able to first elucidate mechanisms behind perturba-
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tions and pathologies and in turn develop novel therapeutics. Our ability to devise and
characterise complex circuits with a hierarchical output is rapidly evolving. However,
these circuits need to truly function in a robust and pre-determined state if they are to
ever be used for the production and delivery of therapeutic compounds in vivo.
The use of engineered commensal chassis like EcN provide a promising approach
for the development of these therapeutics. Building on the wealth of tools available
for E.coli, it is relatively convenient to develop approaches based on the ‘laboratory
friendly’ EcN strain. Indeed, this is currently reflected in the biotechnology industry
where Synlogic Therapeutics (Boston, USA) is using EcN as a chassis for a novel class
of medicines. Through the use of EcN, they have designed an orally administered strain
that harbours a complementary metabolic pathway that can remove excess ammonia
from the blood of a patient suffering from urea cycle disorders (UCD). They have
recently dosed patients in a Phase 1 clinical trial to assess the safety of the approach
and hope to use the platform as a pipeline for numerous other errors of metabolism
and metabolic coniditions.
We are slowly uncovering the vast number of strains in the intestines, and in turn
the unique and diverse protein coding genes they harbour. The relevance and merits
of synthetic biology tools need to be coupled to the chosen delivery chassis. In light of
this, efforts must also be made to devise tools for strains from the Bacteroidetes and
Firmicutes phyla that are more difficult to work with but colonise the intestines in a
much more abundant and longterm manner. The sheer abundance of these strains in
the intestines could enable the design of much more powerful therapeutic strategies.
Regardless of the chassis chosen to manipulate this complex ecosystem with recombin-
ant DNA, it is imperative that we employ robust biocontainement strategies to prevent
genetic sharing between strains and the escape of the DNA to the environment or other
humans.
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Figure 5.1: Plate-reader OD540 absorbance of OXB20_GFP, OXB20_GFP_AT,
OXB20_GFP_HS and OXB20_GFP_MCC over 37 daily passages in the absence of
antibiotic selection. OXBK, ATK, HSK and MCCK indicate control wells grown with
both erythromycin and kanamycin that should be 100% plasmid-bearing. Ecn and ecnk
indicate negative controls. Numbers indicate biological replicates and colours indicate
technical replicates.
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Figure 5.2: Plate-reader luminescence of OXB20_GFP, OXB20_GFP_AT,
OXB20_GFP_HS and OXB20_GFP_MCC over 37 daily passages in the absence of
antibiotic selection. OXBK, ATK, HSK and MCCK indicate control wells grown with
both erythromycin and kanamycin that should be 100% plasmid-bearing. Ecn and ecnk
indicate negative controls. Numbers indicate biological replicates and colours indicate
technical replicates.
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Figure 5.3: Restriction enzyme digests identifying the presence of the
OXB20_GFP_AT plasmid in EcN_Lux after 37 daily passages in the absence
of antibiotic selection. Lane 1-9 indicate the 9 replicates grown only in erythromycin
and lanes 10-12 indicate the control strains grown in erythromycin and kanamycin.
Simulated digests on the bottom right show the two EcN cryptic plasmids (at 5164bp
and 3177bp) and the 4 identifiable fragments of the OXB20_GFP_AT plasmid.
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Figure 5.4: Restriction enzyme digests identifying the partial presence of the
OXB20_GFP_MCC plasmid in EcN_Lux after 37 daily passages in the absence of
antibiotic selection. Lane 1-9 indicate the 9 replicates grown only in erythromycin and
lanes 10-12 indicate the control strains grown in erythromycin and kanamycin. Simu-
lated digests on the bottom right show the two EcN cryptic plasmids (at 5164bp and
3177bp) and the 4 identifiable fragments of the OXB20_GFP_MCC plasmid. Digests
correlate with fluorescence data indicating that the plasmid was only present in 4 out
of 9 replicates (lane 1,6, 8 and 9).
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Figure 5.5: EcN_pProE_GFP induction after 16 hours in M9 media with 0M Pro-
pionate. Top, histogram density plot of GFP fluorescence after 16 hours induction.
Bottom, median GFP fluorescence over 16 hours. Flow cytometry data with 10,000
events (n=3).
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Figure 5.6: EcN_pYeaR_GFP induction on an agar plate at different distances from
the uninduced EcB_pNOSBan centre. Top, histogram density plot of GFP fluorescence
after 16 hours growth. Bottom, median GFP fluorescence after 16 hours growth. Flow
cytometry data with 10,000 events (n=3).
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Figure 5.7: EcN_OG241_GFP (negative promoterless control) induction after 16 hours
in LB media buffered to pH 5 (with acetic acid), pH 6 (with MES), pH 7 (with HEPES)
and pH 8 (with HEPES). Top, histogram density plot of GFP fluorescence after 16 hours
growth. Bottom, median GFP fluorescence after 16 hours growth. Flow cytometry data
with 10,000 events (n=3).
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Figure 5.8: EcN_OXB19_GFP (positive constitutive control) induction after 16 hours
in LB media buffered to pH 5 (with acetic acid), pH 6 (with MES), pH 7 (with HEPES)
and pH 8 (with HEPES). Top, histogram density plot of GFP fluorescence after 16 hours
growth. Bottom, median GFP fluorescence after 16 hours growth. Flow cytometry data
with 10,000 events (n=3).
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Ratiometric Bacterial Sensors
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Figure 5.9: GFP:mCherry ratio in EcN_OXB19_GFP_mCherry and
EcN_OG241_GFP_mCherry With Increasing OD700. Ratio calculated using
median fluorescence for each reporter from flow cytometry data with 10,000 events
(n=3).
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Figure 5.10: GFP to mCherry ratio in uninduced or induced (1mM IPTG)
EcN_pLac_GFP_mCherry with increasing OD700. Ratio calculated using median
fluorescence for each reporter from flow cytometry data with 10,000 events (n=3).
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Figure 5.11: Box plot of GFP:mCherry ratio in individual 7 day old C.elegans worms
grown on EcN_OG241_GFP_mCherry and EcN_OXB19_GFP_mCherry control
strains and transferred to a NGM plate supplemented with 1mM IPTG for 8 hours.
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